10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2021

OR

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the transition period from to

Commission File Number 001-38103

JANUS HENDERSON GROUP PLC

(Exact name of registrant as specified in its charter)

Jersey, Channel Islands (State or other jurisdiction of incorporation or organization)	98-1376360 (I.R.S. Employer Identification No.)
201 Bishopsgate London, United Kingdom (Address of principal executive offices)	EC2M3AE (Zip Code)

+44 (0) 20 7818 1818

(Registrant’s telephone number, including area code)

N/A
(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, $1.50 Per Share Par Value	JHG	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Company was required to file such reports), and (2) has been subject to the filing requirements for the past 90 days. Yes ⌧ No ◻

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ⌧ No ◻

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “non-accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large Accelerated Filer ⌧ Accelerated Filer ◻ Non-Accelerated Filer ◻ Smaller Reporting Company ☐ Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ⌧

As of October 25, 2021, there were 170,584,530 shares of the Company’s common stock, $1.50 par value per share, issued and outstanding.

PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(U.S. Dollars in Millions, Except Share Data)

	September 30,		December 31,
	2021		2020
ASSETS
Current assets:
Cash and cash equivalents	$	933.1	$	1,099.7
Investment securities		445.2		268.1
Fees and other receivables		359.5		373.6
OEIC and unit trust receivables		180.7		114.7
Assets of consolidated VIEs:
Cash and cash equivalents		11.5		8.4
Investment securities		245.3		214.6
Other current assets		2.0		3.5
Other current assets		122.0		111.1
Total current assets		2,299.3		2,193.7
Non-current assets:
Property, equipment and software, net		63.7		77.9
Intangible assets, net		2,620.9		2,686.3
Goodwill		1,370.8		1,383.9
Retirement benefit asset, net		189.8		191.3
Other non-current assets		158.7		157.7
Total assets	$	6,703.2	$	6,690.8
LIABILITIES
Current liabilities:
Accounts payable and accrued liabilities	$	229.4	$	232.1
Current portion of accrued compensation, benefits and staff costs		351.0		371.0
OEIC and unit trust payables		189.6		121.5
Liabilities of consolidated VIEs:
Accounts payable and accrued liabilities		2.9		3.2
Total current liabilities		772.9		727.8
Non-current liabilities:
Accrued compensation, benefits and staff costs		36.9		53.7
Long-term debt		311.1		313.3
Deferred tax liabilities, net		644.7		627.4
Retirement benefit obligations, net		4.7		4.7
Other non-current liabilities		125.6		144.3
Total liabilities		1,895.9		1,871.2
Commitments and contingencies (See Note 14)
REDEEMABLE NONCONTROLLING INTERESTS		145.1		85.8
EQUITY
Common stock, $1.50 par value; 480,000,000 shares authorized, and 170,584,530 and 180,403,176 shares issued and outstanding as of September 30, 2021, and December 31, 2020, respectively		255.9		270.6
Additional paid-in-capital		3,755.4		3,815.0
Treasury shares, 1,208,917 and 2,548,063 shares held at September 30, 2021, and December 31, 2020, respectively		(58.1)		(107.3)
Accumulated other comprehensive loss, net of tax		(376.9)		(324.0)
Retained earnings		1,070.3		1,062.1
Total shareholders’ equity		4,646.6		4,716.4
Nonredeemable noncontrolling interests		15.6		17.4
Total equity		4,662.2		4,733.8
Total liabilities, redeemable noncontrolling interests and equity	$	6,703.2	$	6,690.8

The accompanying notes are an integral part of these condensed consolidated financial statements.

1

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED)

(U.S. Dollars in Millions, Except per Share Data)

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Revenue:
Management fees	$	564.5	$	457.7	$	1,623.5	$	1,305.0
Performance fees		0.6		7.0		95.0		38.8
Shareowner servicing fees		67.6		53.7		192.4		151.3
Other revenue		54.7		50.1		158.9		146.3
Total revenue		687.4		568.5		2,069.8		1,641.4
Operating expenses:
Employee compensation and benefits		166.2		154.9		533.2		456.3
Long-term incentive plans		35.0		42.7		138.3		125.4
Distribution expenses		142.1		118.8		404.3		335.7
Investment administration		13.0		13.1		38.7		37.4
Marketing		7.5		5.3		20.4		15.7
General, administrative and occupancy		65.5		65.6		194.2		188.8
Impairment of goodwill and intangible assets		-		-		44.4		513.7
Depreciation and amortization		9.8		11.6		30.5		37.6
Total operating expenses		439.1		412.0		1,404.0		1,710.6
Operating income (loss)		248.3		156.5		665.8		(69.2)
Interest expense		(3.2)		(3.2)		(9.6)		(9.7)
Investment gains, net		4.7		25.5		8.1		25.3
Other non-operating income (expenses), net		3.6		(0.9)		0.8		39.9
Income (loss) before taxes		253.4		177.9		665.1		(13.7)
Income tax provision		(53.3)		(40.8)		(176.1)		(2.1)
Net income (loss)		200.1		137.1		489.0		(15.8)
Net loss (income) attributable to noncontrolling interests		(3.3)		(18.2)		0.6		(9.4)
Net income (loss) attributable to JHG	$	196.8	$	118.9	$	489.6	$	(25.2)
Earnings (loss) per share attributable to JHG common shareholders:
Basic	$	1.15	$	0.65	$	2.82	$	(0.14)
Diluted	$	1.14	$	0.65	$	2.81	$	(0.14)
Other comprehensive income (loss), net of tax:
Foreign currency translation gains (losses)	$	(59.6)	$	97.4	$	(53.1)	$	(41.1)
Actuarial gains		0.1		0.1		0.4		0.3
Other comprehensive income (loss), net of tax		(59.5)		97.5		(52.7)		(40.8)
Other comprehensive loss (income) attributable to noncontrolling interests		0.8		(11.0)		(0.2)		(7.3)
Other comprehensive income (loss) attributable to JHG	$	(58.7)	$	86.5	$	(52.9)	$	(48.1)
Total comprehensive income (loss)	$	140.6	$	234.6	$	436.3	$	(56.6)
Total comprehensive loss (income) attributable to noncontrolling interests		(2.5)		(29.2)		0.4		(16.7)
Total comprehensive income (loss) attributable to JHG	$	138.1	$	205.4	$	436.7	$	(73.3)

The accompanying notes are an integral part of these condensed consolidated financial statements.

2

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(U.S. Dollars in Millions)

	Nine months ended
	September 30,
	2021		2020
CASH FLOWS PROVIDED BY (USED FOR):
Operating activities:
Net income (loss)	$	489.0	$	(15.8)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization		30.5		37.6
Impairment of goodwill and intangible assets		44.4		513.7
Deferred income taxes		24.2		(109.8)
Stock-based compensation plan expense		50.7		52.2
Impairment of right-of-use operating asset		-		1.3
Gain on sale of Geneva		-		(16.2)
Investment gains, net		(8.1)		(25.3)
Contributions to pension plans in excess of costs recognized		(1.0)		(0.4)
Contingent consideration fair value adjustment		-		(7.1)
Other, net		(7.4)		(14.7)
Changes in operating assets and liabilities:
OEIC and unit trust receivables and payables		2.1		8.5
Other assets		(14.0)		54.9
Other accruals and liabilities		3.8		(53.4)
Net operating activities		614.2		425.5
Investing activities:
Sales (purchases) of:
Investment securities, net		(196.5)		48.8
Property, equipment and software		(5.9)		(16.5)
Investment securities by consolidated seeded investment products, net		(58.0)		(64.8)
Cash paid on settled seed capital hedges, net		(12.6)		(0.1)
Dividends received from equity-method investments		1.1		0.4
Receipt of contingent consideration payments from sale of Volantis		0.7		2.2
Receipt of contingent consideration payments from sale of Geneva		5.4		1.6
Proceeds from sale of Geneva		-		38.4
Net investing activities		(265.8)		10.0
Financing activities:
Proceeds from stock-based compensation plans		10.9		(0.1)
Purchase of common stock for stock-based compensation plans		(72.1)		(48.4)
Purchase of common stock from Dai-ichi Life and share buyback program		(305.2)		(103.4)
Dividends paid to shareholders		(191.5)		(198.1)
Payment of contingent consideration		-		(13.8)
Distributions to noncontrolling interests		(0.4)		(0.5)
Third-party sales in consolidated seeded investment products, net		61.2		64.8
Principal payments under capital lease obligations		(0.3)		(0.3)
Net financing activities		(497.4)		(299.8)
Cash and cash equivalents:
Effect of foreign exchange rate changes		(14.5)		(5.7)
Net change		(163.5)		130.0
At beginning of period		1,108.1		796.5
At end of period	$	944.6	$	926.5
Supplemental cash flow information:
Cash paid for interest	$	14.6	$	14.6
Cash paid for income taxes, net of refunds	$	169.2	$	130.6
Reconciliation of cash and cash equivalents:
Cash and cash equivalents	$	933.1	$	909.0
Cash and cash equivalents held in consolidated VIEs		11.5		17.5
Total cash and cash equivalents	$	944.6	$	926.5

The accompanying notes are an integral part of these condensed consolidated financial statements.

3

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)

(Amounts in Millions)

									Accumulated
					Additional				other				Nonredeemable
	Number of		Common		paid-in		Treasury		comprehensive		Retained		noncontrolling		Total
Three months ended September 30, 2021	shares		stock		capital		shares		loss		earnings		interests		equity
Balance at July 1, 2021	172.3	$	258.5	$	3,743.6	$	(67.6)	$	(318.2)	$	1,009.7	$	15.6	$	4,641.6
Net income	—		—		—		—		—		196.8		0.1		196.9
Other comprehensive loss	—		—		—		—		(58.7)		—		—		(58.7)
Dividends paid to shareholders ($0.38 per share)	—		—		—		—		—		(64.8)		—		(64.8)
Purchase of common stock for share buyback program	(1.7)		(2.6)		—		—		—		(72.4)		—		(75.0)
Distributions to noncontrolling interests	—		—		—		—		—		—		(0.1)		(0.1)
Fair value adjustments to redeemable noncontrolling interests	—		—		—		—		—		1.0		—		1.0
Purchase of common stock for stock-based compensation plans	—		—		0.5		(0.6)		—		—		—		(0.1)
Vesting of stock-based compensation plans	—		—		(10.1)		10.1		—		—		—		—
Stock-based compensation plan expense	—		—		16.0		—		—		—		—		16.0
Proceeds from stock-based compensation plans	—		—		5.4		—		—		—		—		5.4
Balance at September 30, 2021	170.6	$	255.9	$	3,755.4	$	(58.1)	$	(376.9)	$	1,070.3	$	15.6	$	4,662.2

									Accumulated
					Additional				other				Nonredeemable
	Number of		Common		paid-in		Treasury		comprehensive		Retained		noncontrolling		Total
Three months ended September 30, 2020	shares		stock		capital		shares		loss		earnings		interests		equity
Balance at July 1, 2020	183.9	$	275.8	$	3,792.1	$	(114.6)	$	(501.7)	$	959.2	$	18.1	$	4,428.9
Net income (loss)	—		—		—		—		—		118.9		(0.5)		118.4
Other comprehensive income	—		—		—		—		86.5		—		—		86.5
Dividends paid to shareholders ($0.36 per share)	—		—		—		—		—		(65.5)		—		(65.5)
Purchase of common stock for share buyback program	(2.5)		(3.7)		—		—		—		(46.5)		—		(50.2)
Fair value adjustments to redeemable noncontrolling interests	—		—		—		—		—		(0.3)		—		(0.3)
Purchase of common stock for stock-based compensation plans	—		—		(2.1)		(0.6)		—		—		—		(2.7)
Vesting of stock-based compensation plans	—		—		(4.0)		4.0		—		—		—		—
Stock-based compensation plan expense	—		—		18.1		—		—		—		—		18.1
Proceeds from stock-based compensation plans	—		—		(0.1)		—		—		—		—		(0.1)
Balance at September 30, 2020	181.4	$	272.1	$	3,804.0	$	(111.2)	$	(415.2)	$	965.8	$	17.6	$	4,533.1

4

JANUS HENDERSON GROUP PLC

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED) (Continued)

(Amounts in Millions)

									Accumulated
					Additional				other				Nonredeemable
	Number of		Common		paid-in		Treasury		comprehensive		Retained		noncontrolling		Total
Nine months ended September 30, 2021	shares		stock		capital		shares		loss		earnings		interests		equity
Balance at January 1, 2021	180.4	$	270.6	$	3,815.0	$	(107.3)	$	(324.0)	$	1,062.1	$	17.4	$	4,733.8
Net income (loss)	—		—		—		—		—		489.6		(1.4)		488.2
Other comprehensive loss	—		—		—		—		(52.9)		—		—		(52.9)
Dividends paid to shareholders ($1.12 per share)	—		—		0.1		—		—		(191.6)		—		(191.5)
Purchase of common stock from Dai-ichi Life and share buyback program	(9.8)		(14.7)		—		—		—		(290.5)		—		(305.2)
Distributions to noncontrolling interests	—		—		—		—		—		—		(0.4)		(0.4)
Fair value adjustments to redeemable noncontrolling interests	—		—		—		—		—		0.7		—		0.7
Purchase of common stock for stock-based compensation plans	—		—		(70.9)		(1.2)		—		—		—		(72.1)
Vesting of stock-based compensation plans	—		—		(50.4)		50.4		—		—		—		—
Stock-based compensation plan expense	—		—		50.7		—		—		—		—		50.7
Proceeds from stock-based compensation plans	—		—		10.9		—		—		—		—		10.9
Balance at September 30, 2021	170.6	$	255.9	$	3,755.4	$	(58.1)	$	(376.9)	$	1,070.3	$	15.6	$	4,662.2
									Accumulated
					Additional				other				Nonredeemable
	Number of		Common		paid-in		Treasury		comprehensive		Retained		noncontrolling		Total
Nine months ended September 30, 2020	shares		stock		capital		shares		loss		earnings		interests		equity
Balance at January 1, 2020	187.0	$	280.5	$	3,828.5	$	(139.5)	$	(367.1)	$	1,284.1	$	19.7	$	4,906.2
Net loss	—		—		—		—		—		(25.2)		(1.6)		(26.8)
Other comprehensive loss	—		—		—		—		(48.1)		—		—		(48.1)
Dividends paid to shareholders ($1.08 per share)	—		—		0.1		—		—		(198.2)		—		(198.1)
Purchase of common stock for share buyback program	(5.6)		(8.4)		—		—		—		(95.0)		—		(103.4)
Distributions to noncontrolling interests	—		—		—		—		—		—		(0.5)		(0.5)
Fair value adjustments to redeemable noncontrolling interests	—		—		—		—		—		0.1		—		0.1
Purchase of common stock for stock-based compensation plans	—		—		(44.9)		(3.5)		—		—		—		(48.4)
Vesting of stock-based compensation plans	—		—		(31.8)		31.8		—		—		—		—
Stock-based compensation plan expense	—		—		52.2		—		—		—		—		52.2
Proceeds from stock-based compensation plans	—		—		(0.1)		—		—		—		—		(0.1)
Balance at September 30, 2020	181.4	$	272.1	$	3,804.0	$	(111.2)	$	(415.2)	$	965.8	$	17.6	$	4,533.1

The accompanying notes are an integral part of these condensed consolidated financial statements. 

5

JANUS HENDERSON GROUP PLC

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

Note 1 — Basis of Presentation and Significant Accounting Policies

Basis of Presentation

In the opinion of management of Janus Henderson Group plc (“JHG,” “the Company,” “we,” “us,” “our” and similar terms), the accompanying unaudited condensed consolidated financial statements contain all normal recurring adjustments necessary to fairly state our financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Such financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP are not required for interim reporting purposes and have been condensed or omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the annual consolidated financial statements and notes presented in our Annual Report on Form 10-K for the year ended December 31, 2020. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying financial statements through the issuance date.

Recent Accounting Pronouncements Adopted

Income Taxes

In December 2019, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s initiative to reduce complexity in accounting standards. The ASU eliminates certain exceptions to the general principles of ASC 740, Income Taxes, and simplifies income tax accounting in several areas. We adopted the ASU, which was effective as of January 1, 2021. The adoption of this ASU did not have a material impact on our results of operations or financial position.

Note 2 — Consolidation

Variable Interest Entities

Consolidated Variable Interest Entities

Our consolidated variable interest entities (“VIEs”) as of September 30, 2021, and December 31, 2020, include certain consolidated seeded investment products in which we have an investment and act as the investment manager. The assets of these VIEs are not available to us or our creditors. We may not, under any circumstances, access cash, cash equivalents or other assets held by consolidated VIEs to use in our operating activities or otherwise. In addition, the investors in these VIEs have no recourse to the credit of JHG.

Unconsolidated Variable Interest Entities

The following table presents the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VIEs (in millions):

	September 30,		December 31,
	2021		2020
Unconsolidated VIEs	$	99.8	$	9.6

Our total exposure to unconsolidated VIEs represents the value of our economic ownership interest in the investment securities.

6

Voting Rights Entities

Consolidated Voting Rights Entities

The following table presents the balances related to consolidated voting rights entities (“VREs”) that were recorded on our Condensed Consolidated Balance Sheets, including our net interest in these products (in millions):

	September 30,		December 31,
	2021		2020
Investment securities	$	179.3	$	29.3
Cash and cash equivalents		2.3		2.8
Other current assets		0.8		0.4
Accounts payable and accrued liabilities		(0.9)		(0.1)
Total	$	181.5	$	32.4
Redeemable noncontrolling interests in consolidated VREs		(23.5)		—
JHG's net interest in consolidated VREs	$	158.0	$	32.4

The increase in consolidated VREs is primarily due to approximately $163 million of seed capital investments into certain exchange-traded funds (“ETF”) products in September 2021.

Our total exposure to consolidated VREs represents the value of our economic ownership interest in these seeded investment products.

Unconsolidated Voting Rights Entities

The following table presents the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VREs (in millions):

	September 30,		December 31,
	2021		2020
Unconsolidated VREs	$	56.0	$	63.6

Our total exposure to unconsolidated VREs represents the value of our economic ownership interest in the investment securities.

Note 3 — Investment Securities

Our investment securities as of September 30, 2021, and December 31, 2020, are summarized as follows (in millions):

	September 30,		December 31,
	2021		2020
Seeded investment products:
Consolidated VIEs	$	245.3	$	214.6
Consolidated VREs		179.3		29.3
Unconsolidated VIEs and VREs		155.8		73.2
Separate accounts		54.2		63.5
Pooled investment funds		0.1		0.1
Total seeded investment products		634.7		380.7
Investments related to deferred compensation plans		50.3		96.5
Other investments		5.5		5.5
Total investment securities	$	690.5	$	482.7

7

Trading Securities

Net unrealized gains on investment securities held as of the three and nine months ended September 30, 2021 and 2020, are summarized as follows (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Unrealized gains on investment securities held at period end	$	4.6	$	25.5	$	8.0	$	34.1

Investment Gains, Net

Investment gains, net on our Condensed Consolidated Statements of Comprehensive Income (Loss) included the following for the three and nine months ended September 30, 2021 and 2020 (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Seeded investment products and hedges, net	$	1.4	$	5.2	$	4.4	$	11.2
Third-party ownership interests in seeded investment products		3.0		18.1		(1.1)		8.7
Long Tail Alpha equity method investment		0.2		0.4		2.1		6.1
Deferred equity plan		0.2		1.4		2.3		(1.2)
Other		(0.1)		0.4		0.4		0.5
Investment gains, net	$	4.7	$	25.5	$	8.1	$	25.3

Cash Flows

Cash flows related to investment securities for the nine months ended September 30, 2021 and 2020, are summarized as follows (in millions):

	Nine months ended September 30,
	2021				2020
			Sales,				Sales,
	Purchases		settlements		Purchases		settlements
	and		and		and		and
	settlements		maturities		settlements		maturities
Investment securities by consolidated seeded investment products	$	(66.9)	$	8.9	$	(69.3)	$	4.5
Investment securities		(302.2)		105.7		(109.5)		158.3

8

Note 4 — Derivative Instruments

Derivative Instruments Used to Hedge Seeded Investment Products

We maintain an economic hedge program that uses derivative instruments to mitigate against market volatility of certain seeded investments by using index and commodity futures (“futures”), index swaps, total return swaps (“TRSs”) and credit default swaps. Foreign currency exposures associated with our seeded investment products are also hedged by using foreign currency forward contracts and swaps.

We were party to the following derivative instruments as of September 30, 2021, and December 31, 2020 (in millions):

	Notional value
	September 30, 2021		December 31, 2020
Futures	$	373.6	$	164.5
Credit default swaps		164.4		166.2
Total return swaps		59.6		35.6
Foreign currency forward contracts and swaps		390.3		205.0

The derivative instruments are not designated as hedges for accounting purposes. Changes in fair value of the derivatives are recognized in investment gains, net in our Condensed Consolidated Statements of Comprehensive Income (Loss).

Derivative assets and liabilities are generally recognized on a gross basis and included in other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. The derivative assets and liabilities as of September 30, 2021, and December 31, 2020, are summarized as follows (in millions):

	Fair value
	September 30, 2021		December 31, 2020
Derivative assets	$	12.2	$	9.1
Derivative liabilities		8.6		10.8

In addition to using derivative instruments to mitigate against market volatility of certain seeded investments, we also engage in short sales of securities to hedge seed investments. As of September 30, 2021, and December 31, 2020, the fair value of securities sold but not yet purchased was $2.9 million and $7.9 million, respectively. The cash received from the short sale and the obligation to repurchase the shares are classified in other current assets and accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets, respectively. Fair value adjustments are recognized in investment gains, net on our Condensed Consolidated Statements of Comprehensive Income (Loss).

Derivative Instruments in Consolidated Seeded Investment Products

Certain of our consolidated seeded investment products utilize derivative instruments to contribute to the achievement of defined investment objectives. These derivative instruments are classified within other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. Gains and losses on these derivative instruments are classified within investment gains, net in our Condensed Consolidated Statements of Comprehensive Income (Loss).

9

Our consolidated seeded investment products were party to the following derivative instruments as of September 30, 2021, and December 31, 2020 (in millions):

	Notional value
	September 30, 2021		December 31, 2020
Futures	$	96.4	$	57.0
Credit default swaps		5.5		1.5
Interest rate swaps		3.8		75.0
Options		0.3		0.5
Foreign currency forward contracts and swaps		83.3		56.1

Derivative Instruments — Used in Foreign Currency Hedging Program

In January 2021, we implemented a balance sheet foreign currency hedging program (the “Program”) to take reasonable measures to minimize the effects of foreign currency remeasurement of monetary balance sheet accounts. The Program is not designed to eliminate all impacts of foreign currency risk; rather it is designed to reduce income statement volatility. The Program utilizes foreign currency forward contracts and swaps to achieve its objectives, and it is considered an economic hedge for accounting purposes.

The notional value of the foreign currency forward contracts and swaps was $104.7 million at September 30, 2021. The derivative assets and liabilities are generally recognized on a gross basis and included in other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. The derivative assets and liabilities as of September 30, 2021, are summarized as follows (in millions):

	Fair value
	September 30, 2021
Derivative liabilities	$	1.9

Changes in fair value of the derivatives are recognized in other non-operating income (expenses), net on our Condensed Consolidated Statements of Comprehensive Income (Loss), and we recognized a loss of $0.8 million and a gain of $0.5 million during the three and nine months ended September 30, 2021, respectively. Foreign currency remeasurement is also recognized in other non-operating income (expenses), net on our Condensed Consolidated Statement of Comprehensive Income (Loss).

10

Note 5 — Fair Value Measurements

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of September 30, 2021 (in millions):

	Fair value measurements using:
	Quoted prices in
	active markets for
	identical assets		Significant other		Significant
	and liabilities		observable inputs		unobservable inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Cash equivalents	$	384.5	$	—	$	—	$	384.5
Investment securities:
Consolidated VIEs		194.7		43.8		6.8		245.3
Other investment securities		418.6		26.6		—		445.2
Total investment securities		613.3		70.4		6.8		690.5
Seed hedge derivatives		—		12.2		—		12.2
Derivatives in consolidated seeded investment products		—		0.1		—		0.1
Volantis contingent consideration		—		—		2.0		2.0
Geneva contingent consideration		—		—		12.0		12.0
Total assets	$	997.8	$	82.7	$	20.8	$	1,101.3
Liabilities:
Derivatives in consolidated seeded investment products	$	—	$	0.6	$	—	$	0.6
Derivatives used in foreign currency hedging program		—		1.9		—		1.9
Securities sold, not yet purchased		2.9		—		—		2.9
Seed hedge derivatives		—		8.6		—		8.6
Long-term debt(1)		—		336.8		—		336.8
Deferred bonuses		—		—		42.8		42.8
Total liabilities	$	2.9	$	347.9	$	42.8	$	393.6

(1) Carried at amortized cost and disclosed at fair value.

11

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of December 31, 2020 (in millions):

	Fair value measurements using:
	Quoted prices in
	active markets for
	identical assets		Significant other		Significant
	and liabilities		observable inputs		unobservable inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Cash equivalents	$	525.0	$	—	$	—	$	525.0
Investment securities:
Consolidated VIEs		125.7		77.7		11.2		214.6
Other investment securities		230.9		37.2		—		268.1
Total investment securities		356.6		114.9		11.2		482.7
Seed hedge derivatives		—		9.1		—		9.1
Derivatives in consolidated seeded investment products		—		0.9		—		0.9
Volantis contingent consideration		—		—		2.8		2.8
Geneva contingent consideration		—		—		17.4		17.4
Total assets	$	881.6	$	124.9	$	31.4	$	1,037.9
Liabilities:
Derivatives in consolidated seeded investment products	$	—	$	0.2	$	—	$	0.2
Securities sold, not yet purchased		7.9		—		—		7.9
Seed hedge derivatives		—		10.8		—		10.8
Long-term debt(1)		—		348.4		—		348.4
Deferred bonuses		—		—		65.2		65.2
Total liabilities	$	7.9	$	359.4	$	65.2	$	432.5

(1) Carried at amortized cost and disclosed at fair value.

Level 1 Fair Value Measurements

Our Level 1 fair value measurements consist mostly of investments held by seeded investment products, investments in advised mutual funds, cash equivalents and investments related to deferred compensation plans with quoted market prices in active markets. The fair value level of consolidated investments held by seeded investment products is determined by the underlying securities of the product. The fair value level of unconsolidated investments held in seeded investment products is determined by the net asset value (“NAV”), which is considered a quoted price in an active market.

Level 2 Fair Value Measurements

Our Level 2 fair value measurements consist mostly of consolidated seeded investment products, derivative instruments and our long-term debt. The fair value of consolidated seeded investment products is determined by the underlying securities of the product. The fair value of our long-term debt is determined using broker quotes and recent trading activity, which are considered Level 2 inputs.

12

Level 3 Fair Value Measurements

Investment Securities

As of September 30, 2021, and December 31, 2020, certain securities within consolidated VIEs were valued using significant unobservable inputs, resulting in Level 3 classification. In addition, we have an investment in a private equity vehicle where the significant valuation inputs are unobservable.

Geneva Contingent Consideration

On December 3, 2019, Henderson Global Investors (North America), Inc. (“HGINA”), a subsidiary of the Company, entered into an agreement to sell its 100% ownership interest in Geneva Capital Management LLC (“Geneva”) to GCM Purchaser, LLC. The sale closed on March 17, 2020. Consideration included aggregate cash consideration of $38.4 million and contingent consideration (the “Earnout”) based on future revenue. Payments under the Earnout are to be made quarterly over a five-year term, with minimum aggregate payments of $20.5 million and maximum aggregate payments of $35.0 million. During the three and nine months ended September 30, 2021, we received a $1.9 million and $5.4 million contingent consideration payment, respectively.

Volantis Contingent Consideration

On April 1, 2017, we completed the sale of the Volantis UK Small Cap (“Volantis”) alternative team assets. Consideration for the sale was a 10% share of the management and performance fees generated by Volantis (excluding one particular fund) for a period of three years following the sale. In addition, consideration for the sale included 50% of the first £12 million of performance fees generated by the excluded fund referenced above. As of September 30, 2021, the fund has not reached the £12 million performance fee threshold. As a result, this fee sharing arrangement will remain in effect until the performance threshold is reached.

As of September 30, 2021, and December 31, 2020, the fair value of the Volantis contingent consideration was $2.0 million and $2.8 million, respectively.

Deferred Bonuses

Deferred bonuses represent liabilities to employees over the vesting period that will be settled by investments in our products. The significant unobservable inputs used to value the liabilities are investment designations and vesting periods.

Changes in Fair Value

Changes in fair value of our Level 3 assets for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Beginning of period fair value	$	26.5	$	29.2	$	31.4	$	12.8
Contingent consideration from sale of Geneva		—		(1.4)		—		18.9
Settlements		(5.2)		—		(9.2)		(2.2)
Fair value adjustments		(0.2)		(1.6)		(2.7)		(3.3)
Purchases of securities		—		0.2		2.7		0.5
Sales of securities		—		—		(1.1)		—
Foreign currency translation		(0.3)		0.2		(0.3)		(0.1)
End of period fair value	$	20.8	$	26.6	$	20.8	$	26.6

13

Changes in fair value of our individual Level 3 liabilities for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021		2020
	Deferred		Deferred
	bonuses		bonuses
Beginning of period fair value	$	35.6	$	42.9
Fair value adjustments		1.1		0.8
Vesting of deferred bonuses		(0.9)		(1.4)
Amortization of deferred bonuses		7.9		8.1
Foreign currency translation		(0.9)		1.8
End of period fair value	$	42.8	$	52.2

	Nine months ended September 30,
	2021		2020
	Deferred		Contingent		Deferred
	bonuses		consideration		bonuses
Beginning of period fair value	$	65.2	$	21.2	$	76.6
Fair value adjustments		5.4		(7.1)		(0.3)
Vesting of deferred bonuses		(51.6)		—		(48.1)
Amortization of deferred bonuses		24.0		—		26.7
Unrealized gains (losses)		—		0.3		—
Distributions		—		(13.8)		—
Foreign currency translation		(0.2)		(0.6)		(2.7)
End of period fair value	$	42.8	$	—	$	52.2

Nonrecurring Fair Value Measurements

Nonrecurring Level 3 fair value measurements include goodwill and intangible assets. We measure the fair value of goodwill and intangible assets on initial recognition using discounted cash flow (“DCF”) analysis that requires assumptions regarding projected future earnings and discount rates. Because of the significance of the unobservable inputs in the fair value measurements of these assets, such measurements are classified as Level 3.

Note 6 — Goodwill and Intangible Assets

The following tables present movements in our intangible assets and goodwill during the nine months ended September 30, 2021 and 2020 (in millions):

	December 31,								Foreign  currency		September 30,
	2020		Amortization		Disposal		Impairment		translation		2021
Indefinite-lived intangible assets:
Investment management agreements	$	2,242.9	$	—	$	—	$	(40.8)	$	(13.7)	$	2,188.4
Trademarks		373.2		—		—		(3.6)		(0.1)		369.5
Definite-lived intangible assets:
Client relationships		170.9		—		—		—		(2.9)		168.0
Accumulated amortization		(100.7)		(5.8)		—		—		1.5		(105.0)
Net intangible assets	$	2,686.3	$	(5.8)	$	—	$	(44.4)	$	(15.2)	$	2,620.9
Goodwill	$	1,383.9	$	—	$	—	$	—	$	(13.1)	$	1,370.8

14

	December 31,								Foreign  currency		September 30,
	2019		Amortization		Disposal		Impairment		translation		2020
Indefinite-lived intangible assets:
Investment management agreements	$	2,490.3	$	—	$	—	$	(263.5)	$	(12.7)	$	2,214.1
Trademarks		380.8		—		—		(7.7)		(0.1)		373.0
Definite-lived intangible assets:
Client relationships		364.7		—		(79.3)		(119.0)		(0.3)		166.1
Accumulated amortization		(147.2)		(10.5)		61.4		—		0.6		(95.7)
Net intangible assets	$	3,088.6	$	(10.5)	$	(17.9)	$	(390.2)	$	(12.5)	$	2,657.5
Goodwill	$	1,504.3	$	—	$	(23.5)	$	(123.5)	$	(15.4)	$	1,341.9

Interim Impairment Assessment

During the second quarter of 2021, we performed an interim impairment assessment on a certain indefinite-lived intangible asset due to a significant decrease in assets under management (“AUM”) and unfavorable changes in the forecast on these specific assets. A DCF model was used to determine the estimated fair value of the investment management agreements. Some of the inputs used in the DCF model required significant management judgment, including the discount rate, terminal growth rate, forecasted financial results and market returns. The results of the DCF model revealed a fair value of nil and we therefore impaired the entire $40.8 million balance of the intangible asset. The impairment charge is included in the table above and recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

Perkins Trademark

During the first quarter of 2021, as part of our ongoing strategic initiatives and looking globally at delivering excellent service to our clients and positioning our business for success, we completed a review of Perkins Investment Management (“Perkins”). To right-size our product portfolio and better align with the changing needs of clients, certain strategies were closed and the funds were liquidated during the second quarter of 2021. The majority of the Perkins value equity strategies were unaffected by this reorganization and they have continued under the Janus Henderson brand. The Perkins brand was discontinued and the marketing efforts for value equity strategies were incorporated under the Janus Henderson brand. During the first quarter 2021, we impaired the entire balance of the intangible asset associated with the Perkins trademark. The impairment charge of $3.6 million is included in the table above and recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

Sale of Geneva

On December 3, 2019, HGINA, a subsidiary of JHG, entered into an agreement to sell its 100% ownership interest in Geneva to GCM Purchaser, LLC. The sale closed on March 17, 2020. The transaction included $17.9 million of net intangible assets and goodwill of $23.5 million, as disclosed in the disposal column above.

2020 Goodwill and Intangible Asset Impairments

In March 2020, the World Health Organization declared COVID-19 a pandemic, and global financial markets declined. This drove a sudden and severe decline in our AUM, which was a triggering event for performing an interim impairment assessment of our goodwill and intangible assets. Our interim impairment assessment revealed the carrying value of certain investment management agreements, trademarks, client relationships and goodwill exceeded their estimated fair value, and we recognized impairments of $263.5 million, $7.7 million, $92.6 million and $123.5 million, respectively, during the three months ended March 31, 2020. The results of the March 2020 interim assessment are included in the table above. The impairment charges were recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

15

VelocityShares Exchange-Traded Notes

In June 2020, a third-party issuer announced its intent to delist and suspend further issuances of the majority of VelocityShares exchange-traded notes (“ETNs”). The announcement was considered a triggering event for performing an interim impairment assessment of the definite-lived intangible asset. We qualitatively assessed the asset and considered how the announcement is expected to negatively impact ETN asset levels in the short and long term. While there will likely continue to be short-term revenue associated with the ETNs after they are delisted, the asset value is expected to decrease until the products become fully liquidated. As such, we impaired the entire intangible asset associated with the VelocityShares ETNs in June 2020. The impairment charge of $26.4 million is included in the table above and recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

Future Amortization

Expected future amortization expense related to client relationships is summarized below (in millions):

Future amortization	Amount
2021 (remainder of year)	$	1.9
2022		7.6
2023		7.3
2024		5.9
2025		5.9
Thereafter		34.4
Total	$	63.0

Note 7 — Debt

Our debt as of September 30, 2021, and December 31, 2020, consisted of the following (in millions):

	September 30, 2021				December 31, 2020
	Carrying		Fair		Carrying		Fair
	value		value		value		value
4.875% Senior Notes due 2025	$	311.1	$	336.8	$	313.3	$	348.4

4.875% Senior Notes Due 2025

The 4.875% Senior Notes due 2025 (“2025 Senior Notes”) have a principal value of $300.0 million, pay interest at 4.875% semiannually on February 1 and August 1 of each year, and mature on August 1, 2025. The 2025 Senior Notes include unamortized debt premium, net at September 30, 2021, of $11.1 million, which will be amortized over the remaining life of the notes. The unamortized debt premium is recorded as a liability within long-term debt on our Condensed Consolidated Balance Sheets. JHG fully and unconditionally guarantees the obligations of Janus Capital Group Inc. (“JCG”) in relation to the 2025 Senior Notes.

16

Credit Facility

At September 30, 2021, we had a $200 million, unsecured, revolving credit facility (“Credit Facility”). JHG and its subsidiaries may use the Credit Facility for general corporate purposes. The rate of interest for each interest period is the aggregate of the applicable margin, which is based on our long-term credit rating and the London Interbank Offered Rate (“LIBOR”); the Euro Interbank Offered Rate (“EURIBOR”) in relation to any loan in euro (“EUR”); or in relation to any loan in Australian dollar (“AUD”), the benchmark rate for that currency. As LIBOR is scheduled to be phased out at the end of 2021, we are working with our banking syndicate to find a suitable replacement. We are required to pay a quarterly commitment fee on any unused portion of the Credit Facility, which is also based on our long-term credit rating. Under the Credit Facility, our financing leverage ratio cannot exceed 3.00x EBITDA. At September 30, 2021, we were in compliance with all covenants contained in, and there were no outstanding borrowings under, the Credit Facility. The maturity date of the Credit Facility is February 16, 2024.

Note 8 — Income Taxes

Our effective tax rates for the three and nine months ended September 30, 2021 and 2020, were as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Effective tax rate	21.0	%	22.9	%	26.5	%	(15.3)	%

The change in the three months ended September 30, 2020 and the three months ended September 30, 2021 is primarily related to the enactment of Finance Act 2020, where the United Kingdom (“UK”) government announced the UK tax rate would remain at 19% and not reduce to 17% as scheduled, resulting in a deferred tax expense in the three months ended September 30, 2020.

The effective tax rate for the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was impacted by the enactment of Finance Act 2021 during the second quarter of 2021, which increased the UK corporation tax rate from 19% to 25% beginning in April 2023. As a result, the UK deferred tax assets and liabilities expected to be settled after 2023 were revalued from 19% to 25%, creating a non-cash deferred tax expense of $31.0 million. The effective tax rate for the nine months ended September 30, 2020, was also impacted by the enactment of Finance Act 2020, as discussed above. In addition, there were significant impairments of intangible assets and goodwill in the first quarter of 2020, which contributed to a pre-tax book loss for the nine months ended September 30, 2020. The majority of the impairment charges were related to temporary differences, which adjusted deferred income taxes and did not have a direct impact on the effective tax rate.

As of September 30, 2021, and December 31, 2020, we had $14.9 million and $15.8 million of unrecognized tax benefits held for uncertain tax positions, respectively. We estimate that the existing liability for uncertain tax positions could decrease by up to $0.6 million within the next 12 months, without giving effect to changes in foreign currency translation.

17

Note 9 — Noncontrolling Interests

Redeemable Noncontrolling Interests

Redeemable noncontrolling interests as of September 30, 2021, and December 31, 2020, consisted of the following (in millions):

	September 30,		December 31,
	2021		2020
Consolidated seeded investment products	$	130.2	$	70.6
Intech:
Employee appreciation rights		12.7		12.3
Founding member ownership interests		2.2		2.9
Total redeemable noncontrolling interests	$	145.1	$	85.8

Consolidated Seeded Investment Products

Noncontrolling interests in consolidated seeded investment products are classified as redeemable noncontrolling interests when there is an obligation to repurchase units at the investor’s request.

Redeemable noncontrolling interests in consolidated seeded investment products may fluctuate from period to period and are impacted by changes in our relative ownership, changes in the amount of third-party investment in seeded products and volatility in the market value of the underlying securities included in the portfolios of seeded products. Redemptions of investments by third parties in any particular seeded product are redeemed from the net assets of such seeded product and cannot be redeemed from the assets of our other seeded products or from our other assets.

The following table presents the movement in redeemable noncontrolling interests in consolidated seeded investment products for the three and nine months ended September 30, 2021 and 2020 (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Opening balance	$	109.2	$	453.7	$	70.6	$	662.8
Changes in market value		3.0		18.8		0.6		10.9
Changes in ownership		18.4		(413.1)		58.5		(610.0)
Foreign currency translation		(0.4)		11.4		0.5		7.1
Closing balance	$	130.2	$	70.8	$	130.2	$	70.8

Intech

Intech Investment Management LLC (“Intech”) ownership interests held by a founding member had an estimated fair value of $2.2 million as of September 30, 2021, representing an approximate 1.1% ownership of Intech. This founding member is entitled to retain his remaining Intech interests for the remainder of his life and has the option to require us to purchase his ownership interests in Intech at fair value.

Intech employee appreciation rights are amortized using a graded vesting method over the respective vesting period. The appreciation rights are exercisable upon termination of employment from Intech to the extent vested. Upon exercise, the appreciation rights are settled in Intech equity.

18

Nonredeemable Noncontrolling Interests

Nonredeemable noncontrolling interests as of September 30, 2021, and December 31, 2020, were as follows (in millions):

	September 30,		December 31,
	2021		2020
Nonredeemable noncontrolling interests in:
Seed capital investments	$	2.9	$	4.6
Intech		12.7		12.8
Total nonredeemable noncontrolling interests	$	15.6	$	17.4

Note 10 — Long-Term Incentive and Employee Compensation

The following table presents restricted stock and mutual fund awards granted during the three and nine months ended September 30, 2021 (in millions):

	Three months ended		Nine months ended
	September 30,		September 30,
	2021		2021
Restricted stock	$	1.0	$	69.5
Mutual fund awards		0.1		75.5
Total	$	1.1	$	145.0

Restricted stock and mutual fund awards generally vest and will be recognized using a graded vesting method over a three- or four-year period.

Note 11 — Retirement Benefit Plans

We operate defined contribution retirement benefit plans and defined benefit pension plans.

Our primary defined benefit pension plan is the defined benefit section of the Janus Henderson Group UK Pension Scheme (“JHGPS”).

Net Periodic Benefit Credit

The components of net periodic benefit credit in respect of defined benefit plans for the three and nine months ended September 30, 2021 and 2020, include the following (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Service cost	$	(0.2)	$	(0.2)	$	(0.7)	$	(0.6)
Interest cost		(2.8)		(4.3)		(8.4)		(12.9)
Amortization of prior service cost		(0.1)		(0.1)		(0.3)		(0.3)
Expected return on plan assets		3.3		4.7		10.0		13.9
Net periodic benefit credit	$	0.2	$	0.1	$	0.6	$	0.1
Total cost

19

Note 12 — Accumulated Other Comprehensive Loss

Changes in accumulated other comprehensive loss, net of tax for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021						2020
	Foreign		Retirement benefit				Foreign		Retirement benefit
	currency		asset, net		Total		currency		asset, net		Total
Beginning balance	$	(308.1)	$	(10.1)	$	(318.2)	$	(521.0)	$	19.3	$	(501.7)
Other comprehensive income (loss)		(59.6)		—		(59.6)		97.6		(0.2)		97.4
Amounts reclassified from accumulated other comprehensive loss		—		0.1		0.1		(0.2)		0.3		0.1
Total other comprehensive income (loss)		(59.6)		0.1		(59.5)		97.4		0.1		97.5
Less: other comprehensive loss (income) attributable to noncontrolling interests		0.8		—		0.8		(11.0)		—		(11.0)
Ending balance	$	(366.9)	$	(10.0)	$	(376.9)	$	(434.6)	$	19.4	$	(415.2)

	Nine months ended September 30,
	2021						2020
	Foreign		Retirement benefit				Foreign		Retirement benefit
	currency		asset, net		Total		currency		asset, net		Total
Beginning balance	$	(313.6)	$	(10.4)	$	(324.0)	$	(386.2)	$	19.1	$	(367.1)
Other comprehensive income (loss)		(48.9)		0.1		(48.8)		(39.5)		—		(39.5)
Amounts reclassified from accumulated other comprehensive loss		(4.2)		0.3		(3.9)		(1.6)		0.3		(1.3)
Total other comprehensive income (loss)		(53.1)		0.4		(52.7)		(41.1)		0.3		(40.8)
Less: other comprehensive loss (income) attributable to noncontrolling interests		(0.2)		—		(0.2)		(7.3)		—		(7.3)
Ending balance	$	(366.9)	$	(10.0)	$	(376.9)	$	(434.6)	$	19.4	$	(415.2)

The components of other comprehensive income (loss), net of tax for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021						2020
	Pre-tax		Tax		Net		Pre-tax		Tax		Net
	amount		impact		amount		amount		impact		amount
Foreign currency translation adjustments	$	(60.2)	$	0.6	$	(59.6)	$	98.2	$	(0.6)	$	97.6
Retirement benefit asset, net		—		—		—		(0.2)		—		(0.2)
Reclassifications to net income		0.1		—		0.1		0.1		—		0.1
Total other comprehensive income (loss)	$	(60.1)	$	0.6	$	(59.5)	$	98.1	$	(0.6)	$	97.5

20

	Nine months ended September 30,
	2021						2020
	Pre-tax		Tax		Net		Pre-tax		Tax			Net
	amount		impact		Amount		amount		impact			Amount
Foreign currency translation adjustments	$	(50.5)	$	1.6	$	(48.9)	$	(41.0)	$	1.5	$	(39.5)
Retirement benefit asset, net		—		0.1		0.1		—		—		—
Reclassifications to net income		(3.9)		—		(3.9)		(1.3)		—		(1.3)
Total other comprehensive income (loss)	$	(54.4)	$	1.7	$	(52.7)	$	(42.3)	$	1.5	$	(40.8)

Note 13 — Earnings (Loss) and Dividends Per Share

Earnings (Loss) Per Share

The following is a summary of the earnings (loss) per share calculation for the three and nine months ended September 30, 2021 and 2020 (in millions, except per share data):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Net income (loss) attributable to JHG	$	196.8	$	118.9	$	489.6	$	(25.2)
Allocation of earnings to participating stock-based awards		(5.4)		(3.5)		(14.1)		—
Net income (loss) attributable to JHG common shareholders	$	191.4	$	115.4	$	475.5	$	(25.2)
Weighted-average common shares outstanding — basic		167.1		178.4		168.7		180.4
Dilutive effect of nonparticipating stock-based awards		0.7		0.4		0.7		—
Weighted-average common shares outstanding — diluted		167.8		178.8		169.4		180.4
Earnings (loss) per share:
Basic (two class)	$	1.15	$	0.65	$	2.82	$	(0.14)
Diluted (two class)	$	1.14	$	0.65	$	2.81	$	(0.14)

The following instruments are anti-dilutive and have not been included in the weighted-average diluted shares outstanding calculation (in millions):

	Three months ended		Nine months ended
	September 30,		September 30,
	2021	2020	2021	2020
Unvested nonparticipating stock awards	0.3	0.8	0.5	1.5

Dividends Per Share

The payment of cash dividends is within the discretion of our Board of Directors and depends on many factors, including, but not limited to, our results of operations, financial condition, capital requirements, legal requirements and general business conditions.

21

The following is a summary of cash dividends paid during the nine months ended September 30, 2021:

Dividend		Date	Dividends paid		Date
per share		declared	(in US$ millions)		paid
$	0.36	February 3, 2021	$	61.7	March 3, 2021
$	0.38	April 28, 2021	$	65.0	May 27, 2021
$	0.38	July 28, 2021	$	64.8	August 25, 2021

On October 27, 2021, our Board of Directors declared a cash dividend of $0.38 per share. The quarterly dividend will be paid on November 24, 2021, to shareholders of record at the close of business on November 8, 2021.

Note 14 — Commitments and Contingencies

Related Party Transactions

On February 4, 2021, Dai-ichi Life Holdings, Inc. (“Dai-ichi Life”) announced its intention to sell all 30,668,922 shares of JHG common stock it owned by means of a registered secondary public offering. On February 9, 2021, Dai-ichi Life completed the secondary offering, and as part of the offering, we repurchased 8,048,360 shares of common stock from Dai-ichi Life for approximately $230.0 million through Goldman Sachs & Co. LLC (“as underwriter”) at the price at which the shares of common stock were sold to the public in the secondary offering, less the underwriting discount. As a result of the completion of the secondary offering, Dai-ichi Life no longer owns any shares of JHG common stock. We did not receive any proceeds from Dai-ichi Life’s sale of common stock in the secondary offering.

Litigation and Other Regulatory Matters

We are periodically involved in various legal proceedings and other regulatory matters. Although there can be no assurances, based on information currently available, we believe that it is probable that the ultimate outcome of matters that are pending or threatened will not have a material effect on our consolidated financial statements.

With respect to the unaudited financial statements of Janus Henderson Group plc as of and for the three-month and nine-month periods ended September 30, 2021, appearing herein, PricewaterhouseCoopers LLP (United States) reported that they have applied limited procedures in accordance with professional standards for a review of such information. However, their separate report dated October 28, 2021, appearing herein, states that they did not audit and they do not express an opinion on the unaudited financial statements. Accordingly, the degree of reliance on their report on such information should be restricted in light of the limited nature of the review procedures applied. PricewaterhouseCoopers LLP (United States) is not subject to the liability provisions of Section 11 of the Securities Act of 1933 for their report on the unaudited financial statements because that report is not a “report” or a “part” of the registration statement prepared or certified by PricewaterhouseCoopers LLP (United States) within the meaning of Sections 7 and 11 of the Act.

22

Report of Independent Registered Public Accounting Firm

To the Board of Directors and Shareholders of Janus Henderson Group plc

Results of Review of Interim Financial Statements

We have reviewed the accompanying condensed consolidated balance sheet of Janus Henderson Group plc and its subsidiaries (the “Company”) as of September 30, 2021, and the related condensed consolidated statements of comprehensive income (loss) and of changes in equity for the three-month and nine month periods ended September 30, 2021 and 2020 and the condensed consolidated statements of cash flows for the nine month periods ended September 30, 2021 and 2020, including the related notes (collectively referred to as the “interim financial statements”). Based on our reviews, we are not aware of any material modifications that should be made to the accompanying interim financial statements for them to be in conformity with accounting principles generally accepted in the United States of America.

We have previously audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States), the consolidated balance sheet of the Company as of December 31, 2020, and the related consolidated statements of comprehensive income, of changes in equity and of cash flows for the year then ended (not presented herein), and in our report dated February 24, 2021, we expressed an unqualified opinion on those consolidated financial statements. In our opinion, the information set forth in the accompanying consolidated balance sheet information as of December 31, 2020, is fairly stated, in all material respects, in relation to the consolidated balance sheet from which it has been derived.

Basis for Review Results

These interim financial statements are the responsibility of the Company’s management. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. We conducted our review in accordance with the standards of the PCAOB. A review of interim financial information consists principally of applying analytical procedures and making inquiries of persons responsible for financial and accounting matters. It is substantially less in scope than an audit conducted in accordance with the standards of the PCAOB, the objective of which is the expression of an opinion regarding the financial statements taken as a whole. Accordingly, we do not express such an opinion.

/s/ PricewaterhouseCoopers LLP

Denver, Colorado

October 28, 2021

23

Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

Certain statements in this Quarterly Report on Form 10-Q not based on historical facts are “forward-looking statements” within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995, as amended, Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and Section 27A of the Securities Act of 1933, as amended (the “Securities Act”). Such forward-looking statements involve known and unknown risks and uncertainties that are difficult to predict and could cause our actual results, performance or achievements to differ materially from those discussed. These include statements as to our future expectations, beliefs, plans, strategies, objectives, events, conditions, financial performance, prospects or future events. In some cases, forward-looking statements can be identified by the use of words such as “may,” “could,” “expect,” “intend,” “plan,” “seek,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” “likely,” “will,” “would” and similar words and phrases. Forward-looking statements are necessarily based on estimates and assumptions that, while considered reasonable by us and our management, are inherently uncertain. Accordingly, you should not place undue reliance on forward-looking statements, which speak only as of the date they are made, and are not guarantees of future performance. We do not undertake any obligation to publicly update or revise these forward-looking statements.

Various risks, uncertainties, assumptions and factors that could cause our future results to differ materially from those expressed by the forward-looking statements included in this Quarterly Report on Form 10-Q include, but are not limited to, risks, uncertainties, assumptions and factors discussed in our Annual Report on Form 10-K for the year ended December 31, 2020, and this Quarterly Report on Form 10-Q under headings such as “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Quantitative and Qualitative Disclosures About Market Risk,” and in other filings or furnishings made by the Company with the SEC from time to time.

Available Information

We make available free of charge our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K and amendments thereto as soon as reasonably practicable after such filings have been made with the SEC. These reports may be obtained through our Investor Relations website (ir.janushenderson.com) and are available in print at no charge upon request by any shareholder. The contents of our website are not incorporated herein for any purpose. The SEC also maintains an internet site that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC at http://www.sec.gov.

Charters for the Audit Committee, Compensation Committee, Risk Committee, and Nominating and Corporate Governance Committee of our Board of Directors, as well as our Corporate Governance Guidelines, Code of Business Conduct and Code of Ethics for Senior Financial Officers (our “Senior Officer Code”) are posted on our Investor Relations website (ir.janushenderson.com) and are available in print at no charge upon request by any shareholder. Within the time period prescribed by SEC and New York Stock Exchange (“NYSE”) regulations, we will post on our website any amendment to our Senior Officer Code or our Code of Business Conduct and any waivers thereof for directors or executive officers. The information on our website is not incorporated by reference into this report.

Business Overview

We are an independent global asset manager, specializing in active investment across all major asset classes. We actively manage a broad range of investment products for institutional and retail investors across five capabilities: Equities, Fixed Income, Multi-Asset, Quantitative Equities and Alternatives.

Segment Considerations

We are a global asset manager and manage a range of investment products, operating across various product lines, distribution channels and geographic regions. However, information is reported to the chief operating decision-maker, the CEO, on an aggregated basis. Strategic and financial management decisions are determined centrally by the CEO and, on this basis, we operate as a single-segment investment management business.

24

Revenue

Revenue primarily consists of management fees and performance fees. Management fees are generally based on a percentage of the market value of our AUM and are calculated using either the daily, month-end or quarter-end average asset balance in accordance with contractual agreements. Accordingly, fluctuations in the financial markets have a direct effect on our operating results. Additionally, our AUM may outperform or underperform the financial markets and, therefore, may fluctuate in varying degrees from that of the general market.

Performance fees are specified in certain fund and client contracts, and are based on investment performance either on an absolute basis or compared to an established index over a specified period of time. These fees are often subject to a hurdle rate. Performance fees are recognized at the end of the contractual period (typically monthly, quarterly or annually) if the stated performance criteria are achieved. Certain fund and client contracts allow for negative performance fees where there is underperformance against the relevant index.

THIRD QUARTER 2021 SUMMARY

Third Quarter 2021 Highlights

● Solid long-term investment performance, with 72%, 64%, 67% and 86% of our AUM outperforming relevant benchmarks on a one-, three-, five- and 10-year basis, respectively, as of September 30, 2021.

● AUM decreased to $419.3 billion, down 1.9%, from June 30, 2021, primarily due to net outflows of $5.2 million.

● Third quarter 2021 diluted earnings per share was $1.14, or $1.16 on an adjusted basis. Refer to the Non-GAAP Financial Measures section below for information on adjusted non-GAAP figures.

● On October 27, 2021, the Board declared a $0.38 per share dividend for the third quarter 2021.

● On July 28, 2021, the Board approved a new on-market share buyback program, which commenced on August 3, 2021, pursuant to which we repurchased 1,765,459 shares of our common stock and CHESS Depository Interests (“CDIs”) for $75.0 million during the third quarter 2021.

Financial Summary

Results are reported on a U.S. GAAP basis. Adjusted non-GAAP figures are presented in the Non-GAAP Financial Measures section below.

Revenue for the third quarter 2021 was $687.4 million, an increase of $118.9 million, or 21%, from the third quarter 2020, primarily due to increases of $106.8 million in management fees and $13.9 million in shareowner servicing fees driven by an increase in average AUM.

Total operating expenses for the third quarter 2021 were $439.1 million, an increase of $27.1 million, or 7%, compared to operating expenses in the third quarter 2020, primarily due to a $23.3 million increase in distribution expenses driven by an increase in average AUM.

Operating income for the third quarter 2021 was $248.3 million, an increase of $91.8 million, or 59%, compared to the third quarter 2020. Our operating margin was 36.1% in the third quarter 2021 compared to 27.5% in the third quarter 2020.

25

Net income attributable to JHG in the third quarter 2021 was $196.8 million, an increase of $77.9 million, or 66%, compared to the third quarter 2020 due to the factors impacting revenue and operating expense discussed above. In addition, net loss (income) attributable to noncontrolling interests improved by $14.9 million from the third quarter 2020, primarily due to the consolidation of third-party ownership interests in seeded investment products and fair value adjustments in relation to our seeded investment products. This increase was partially offset by a $20.8 million decline in investment gains, net and a $12.5 million increase in our income tax provision, primarily driven by the increase in pre-tax book income.

Investment Performance of Assets Under Management

The following table is a summary of investment performance as of September 30, 2021:

Percentage of AUM outperforming benchmark	1 year		3 years		5 years		10 years
Equities	64	%	56	%	60	%	84	%
Fixed Income	98	%	96	%	96	%	99	%
Multi-Asset	99	%	97	%	97	%	97	%
Quantitative Equities	41	%	2	%	2	%	32	%
Alternatives	94	%	97	%	100	%	100	%
Total JHG	72	%	64	%	67	%	86	%

Assets Under Management

Our AUM as of September 30, 2021, was $419.3 billion, an increase of $17.7 billion, or 4.4%, from December 31, 2020, driven primarily by positive market movements of $33.0 billion, partially offset by net redemptions of $11.0 billion.

Our non-U.S. dollar (“USD”) AUM is primarily denominated in British pounds (“GBP”), EUR and AUD. During the three and nine months ended September 30, 2021 and 2020, the USD strengthened against AUD, GBP and EUR, resulting in a $3.5 billion and $4.3 billion decrease in our AUM, respectively. As of September 30, 2021, approximately 31% of our AUM was non-USD denominated, resulting in a net unfavorable currency effect, particularly in products exposed to GBP.

VelocityShares ETNs and certain index products are not included within our AUM because we are not the named adviser or subadviser to ETNs or index products. VelocityShares ETN assets totaled $0.3 billion and $0.6 billion as of September 30, 2021, and December 31, 2020, respectively. VelocityShares index product assets not included within our AUM totaled $2.1 billion and $2.7 billion as of September 30, 2021, and December 31, 2020, respectively.

26

Our AUM and flows by capability for the three and nine months ended September 30, 2021 and 2020, were as follows (in billions):

	Closing AUM														Closing AUM
	June 30,						Net sales						Reclassifications		September 30,
	2021		Sales		Redemptions(1)		(redemptions)		Markets		FX(2)		and disposals(3)		2021
By capability
Equities	$	240.1	$	7.5	$	(10.1)	$	(2.6)	$	0.3	$	(1.6)	$	—	$	236.2
Fixed Income		80.5		4.7		(4.0)		0.7		(0.2)		(1.5)		—		79.5
Multi-Asset		53.2		2.6		(1.8)		0.8		0.1		(0.2)		—		53.9
Quantitative Equities		43.4		0.1		(4.5)		(4.4)		0.1		—		—		39.1
Alternatives		10.4		1.1		(0.8)		0.3		0.1		(0.2)		—		10.6
Total	$	427.6	$	16.0	$	(21.2)	$	(5.2)	$	0.4	$	(3.5)	$	—	$	419.3

	Closing AUM														Closing AUM
	December 31,						Net sales						Reclassifications		September 30,
	2020		Sales		Redemptions(1)		(redemptions)		Markets		FX(2)		and disposals(3)		2021
By capability
Equities	$	219.4	$	26.6	$	(32.6)	$	(6.0)	$	24.6	$	(1.8)	$	—	$	236.2
Fixed Income		81.5		16.5		(15.5)		1.0		(1.0)		(2.0)		—		79.5
Multi-Asset		48.0		8.0		(5.9)		2.1		4.0		(0.2)		—		53.9
Quantitative Equities		42.0		0.5		(8.3)		(7.8)		4.9		—		—		39.1
Alternatives		10.7		3.5		(3.8)		(0.3)		0.5		(0.3)		—		10.6
Total	$	401.6	$	55.1	$	(66.1)	$	(11.0)	$	33.0	$	(4.3)	$	—	$	419.3

	Closing AUM														Closing AUM
	June 30,						Net sales						Reclassifications		September 30,
	2020		Sales		Redemptions(1)		(redemptions)		Markets		FX(2)		and disposals(3)		2020
By capability
Equities	$	179.1	$	5.8	$	(10.9)	$	(5.1)	$	13.0	$	1.9	$	—	$	188.9
Fixed Income		70.2		5.9		(4.1)		1.8		1.0		2.1		—		75.1
Multi-Asset		40.3		2.3		(1.7)		0.6		2.5		0.2		—		43.6
Quantitative Equities		37.5		1.3		(1.4)		(0.1)		3.2		0.1		—		40.7
Alternatives		9.6		0.5		(0.6)		(0.1)		0.1		0.4		—		10.0
Total	$	336.7	$	15.8	$	(18.7)	$	(2.9)	$	19.8	$	4.7	$	—	$	358.3

	Closing AUM														Closing AUM
	December 31,						Net sales						Reclassifications		September 30,
	2019		Sales		Redemptions(1)		(redemptions)		Markets		FX(2)		and disposals(3)		2020
By capability
Equities	$	204.0	$	22.5	$	(38.7)	$	(16.2)	$	5.6	$	(0.4)	$	(4.1)	$	188.9
Fixed Income		74.8		20.2		(22.5)		(2.3)		2.6		—		—		75.1
Multi-Asset		39.8		8.3		(6.0)		2.3		1.8		(0.1)		(0.2)		43.6
Quantitative Equities		45.2		2.1		(8.1)		(6.0)		1.5		—		—		40.7
Alternatives		11.0		2.0		(3.1)		(1.1)		—		—		0.1		10.0
Total	$	374.8	$	55.1	$	(78.4)	$	(23.3)	$	11.5	$	(0.5)	$	(4.2)	$	358.3

(1) Redemptions include the impact of client transfers, which could result in a positive balance on occasion.

(2) FX reflects movements in AUM resulting from changes in foreign currency rates as non-USD denominated AUM is translated into USD.

27

(3) Reclassifications relate to a reclassification of an existing fund from Equities to Alternatives, and disposals relate to the sale of Geneva.

Our AUM and flows by client type for the three and nine months ended September 30, 2021, were as follows (in billions):

	Closing AUM														Closing AUM
	June 30,						Net sales						Reclassifications		September 30,
	2021		Sales		Redemptions		(redemptions)		Markets		FX		and disposals		2021
By client type:
Intermediary	$	206.7	$	12.9	$	(11.7)	$	1.2	$	0.4	$	(1.6)	$	—	$	206.7
Institutional		133.1		2.5		(8.3)		(5.8)		0.2		(1.7)		—		125.8
Self-directed		87.8		0.6		(1.2)		(0.6)		(0.2)		(0.2)		—		86.8
Total	$	427.6	$	16.0	$	(21.2)	$	(5.2)	$	0.4	$	(3.5)	$	—	$	419.3

	Closing AUM														Closing AUM
	December 31,						Net sales						Reclassifications		September 30,
	2020		Sales		Redemptions		(redemptions)		Markets		FX		and disposals		2021
By client type:
Intermediary	$	192.9	$	42.9	$	(40.6)	$	2.3	$	15.2	$	(1.9)	$	(1.8)	$	206.7
Institutional		127.6		10.0		(21.1)		(11.1)		9.8		(2.3)		1.8		125.8
Self-directed		81.1		2.2		(4.4)		(2.2)		8.0		(0.1)		—		86.8
Total	$	401.6	$	55.1	$	(66.1)	$	(11.0)	$	33.0	$	(4.3)	$	—	$	419.3

Average Assets Under Management

The following table presents our average AUM by capability for the three and nine months ended September 30, 2021 (in billions):

	Average AUM		Average AUM
	Three months ended		Nine months ended
By capability	September 30, 2021		September 30, 2021
Equities	$	243.5	$	234.2
Fixed Income		80.9		80.8
Multi-Asset		54.9		51.8
Quantitative Equities		41.9		42.1
Alternatives		10.7		10.5
Total	$	431.9	$	419.4

Closing Assets Under Management

The following table presents the closing AUM, split by client type and client location, as of September 30, 2021 (in billions):

	Closing AUM
By client type	September 30, 2021
Intermediary	$	206.7
Institutional		125.8
Self-directed		86.8
Total	$	419.3

28

	Closing AUM
By client location	September 30, 2021
North America	$	233.4
EMEA and LatAm		128.1
Asia Pacific		57.8
Total	$	419.3

Valuation of Assets Under Management

The fair value of our AUM is based on the value of the underlying cash and investment securities of our funds, trusts and segregated mandates. A significant proportion of these securities is listed or quoted on a recognized securities exchange or market and is regularly traded thereon; these investments are valued based on unadjusted quoted market prices. Other investments, including over-the-counter (“OTC”) derivative contracts (which are dealt in or through a clearing firm, exchanges or financial institutions), are valued by reference to the most recent official settlement price quoted by the appointed market vendor, and in the event no price is available from this source, a broker quotation may be used. Physical property held is valued monthly by a specialist independent appraiser.

When a readily ascertainable market value does not exist for an investment, the fair value is calculated using a variety of methodologies, including the expected cash flows of its underlying net asset base, taking into account applicable discount rates and other factors; comparable securities or relevant indices; recent financing rounds; revenue multiples; or a combination thereof. Judgment is used to ascertain if a formerly active market has become inactive and to determine fair values when markets have become inactive. Our Fair Value Pricing Committee is responsible for determining or approving these unquoted prices, which are reported to those charged with governance of the funds and trusts. For funds that invest in markets that are closed at their valuation point, an assessment is made daily to determine whether a fair value pricing adjustment is required to the fund’s valuation. This may be due to significant market movements in other correlated open markets, scheduled market closures or unscheduled market closures as a result of natural disaster or government intervention.

Third-party administrators hold a key role in the collection and validation of prices used in the valuation of the securities. Daily price validation is completed using techniques such as day-on-day tolerance movements, invariant prices, excessive movement checks and intra-vendor tolerance checks. Our data management team performs oversight of this process and completes annual due diligence on the processes of third parties.

In other cases, we and the sub-administrators perform a number of procedures to validate the pricing received from third-party providers. For actively traded equity and fixed income securities, prices are received daily from both a primary and secondary vendor. Prices from the primary and secondary vendors are compared to identify any discrepancies. In the event of a discrepancy, a price challenge may be issued to both vendors. Securities with significant day-to-day price changes require additional research, which may include a review of all news pertaining to the issue and issuer, and any corporate actions. All fixed income prices are reviewed by our fixed income trading desk to incorporate market activity information available to our traders. In the event the traders have received price indications from market makers for a particular issue, this information is transmitted to the pricing vendors.

We leverage the expertise of our fund management teams across the business to cross-invest assets and create value for our clients. Where cross investment occurs, assets and flows are identified, and the duplication is removed.

Results of Operations

Foreign Currency Translation

Foreign currency translation impacts our Results of Operations. The translation of GBP to USD is the primary driver of foreign currency translation in expenses. The GBP weakened against the USD during the three and nine months ended September 30, 2021, compared to the three and nine months ended September 30, 2020. Meaningful foreign currency translation impacts to our operating expenses are discussed in the Operating Expenses section below. Revenue is also impacted by foreign currency translation, but the impact is generally determined by the primary currency of the individual funds.

29

Revenue

									Three months		Nine months
	Three months ended				Nine months ended				ended		ended
	September 30,				September 30,				September 30,		September 30,
	2021		2020		2021		2020		2021 vs. 2020		2021 vs. 2020
Revenue (in millions):
Management fees	$	564.5	$	457.7	$	1,623.5	$	1,305.0	23	%	24	%
Performance fees		0.6		7.0		95.0		38.8	(91)	%	n/m	*
Shareowner servicing fees		67.6		53.7		192.4		151.3	26	%	27	%
Other revenue		54.7		50.1		158.9		146.3	9	%	9	%
Total revenue	$	687.4	$	568.5	$	2,069.8	$	1,641.4	21	%	26	%
* n/m - Not meaningful.

Management fees

Management fees increased by $106.8 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily due to the impact of higher average AUM, which caused a $103.1 million increase in management fees and an increase in management fee margins, which led to a $2.4 million increase in management fees.

Management fees increased by $318.5 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily due to the impact of higher average AUM, which caused a $293.7 million increase in management fees and an increase in management fee margins, which led to an $18.4 million increase in management fees.

Performance fees

Performance fees are derived across a number of product ranges. U.S. mutual fund performance fees are recognized on a monthly basis, while all other product range performance fees are recognized on a quarterly or annual basis. The investment management fee paid by each U.S. mutual fund subject to a performance fee is the base management fee plus or minus a performance fee adjustment, as determined by the relative investment performance of the fund compared to a specified benchmark index. Performance fees by product type consisted of the following for the three and nine months ended September 30, 2021 and 2020 (in millions):

									Three months		Nine months
	Three months ended				Nine months ended				ended		ended
	September 30,				September 30,				September 30,		September 30,
	2021		2020		2021		2020		2021 vs. 2020		2021 vs. 2020
Performance fees (in millions):
SICAVs	$	1.0	$	2.8	$	63.6	$	12.2	64	%	n/m	*
UK OEICs and unit trusts		—		6.4		19.2		10.0	100	%	(92)	%
Offshore absolute return funds and other		1.1		0.1		3.5		4.1	n/m	*	15	%
Segregated mandates		—		3.2		4.2		23.5	100	%	82	%
Investment trusts		—		—		12.7		—	n/m	*	n/m	*
U.S. mutual funds		(1.5)		(5.5)		(8.2)		(11.0)	73	%	25	%
Total performance fees	$	0.6	$	7.0	$	95.0	$	38.8	91	%	n/m	*
* n/m - Not meaningful.

30

For the three months ended September 30, 2021, performance fees declined $6.4 million compared to the three months ended September 30, 2020, primarily due to a $6.4 million decrease in UK open ended investment company (“OEIC”) performance fees. These UK OEICs performance fees are mainly related to the absolute return strategy, which switched from a quarterly to annual measurement period. The next annual measurement period runs to May 2022.

For the nine months ended September 30, 2021, performance fees improved $56.2 million compared to the nine months ended September 30, 2020, primarily due to a $51.4 million improvement in Société d’Investissement à Capital Variable (“SICAV”) performance fee crystallizations. The strategies contributing to the improvement in SICAV performance are primarily the absolute return strategy and European equities.

Shareowner servicing fees

Shareowner servicing fees are primarily composed of mutual fund servicing fees, which are driven by AUM. For the three months ended September 30, 2021, servicing fees increased $13.9 million compared to the three months ended September 30, 2020, primarily due to an increase in average AUM.

For the nine months ended September 30, 2021, shareowner servicing fees increased $41.1 million compared to the nine months ended September 30, 2020, primarily due to an increase in average AUM.

Other revenue

Other revenue is primarily composed of 12b-1 distribution fees, general administration charges, VelocityShares ETN fees and other fee revenue. Other revenue increased by $4.6 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily due to an increase of $6.7 million in 12b-1 fees and servicing fees driven by an improvement in average AUM, which was partially offset by a $1.9 million decrease in ETN licensing fees due to the delisting and the ongoing liquidation of VelocityShares ETNs.

Other revenue increased by $12.6 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily due to an increase of $14.7 million in 12b-1 fees and servicing fees driven by an improvement in average AUM, as well as a $6.7 million increase in general administration charges due to higher AUM. These increases were partially offset by a $10.1 million decrease in ETN licensing fees due to the delisting and the ongoing liquidation of VelocityShares ETNs.

Operating Expenses

									Three months		Nine months
	Three months ended				Nine months ended				ended		ended
	September 30,				September 30,				September 30,		September 30,
	2021		2020		2021		2020		2021 vs. 2020		2021 vs. 2020
Operating expenses (in millions):
Employee compensation and benefits	$	166.2	$	154.9	$	533.2	$	456.3	7	%	17	%
Long-term incentive plans		35.0		42.7		138.3		125.4	(18)	%	10	%
Distribution expenses		142.1		118.8		404.3		335.7	20	%	20	%
Investment administration		13.0		13.1		38.7		37.4	(1)	%	3	%
Marketing		7.5		5.3		20.4		15.7	42	%	30	%
General, administrative and occupancy		65.5		65.6		194.2		188.8	(0)	%	3	%
Impairment of goodwill and intangible assets		—		—		44.4		513.7	—	%	(91)	%
Depreciation and amortization		9.8		11.6		30.5		37.6	(16)	%	(19)	%
Total operating expenses	$	439.1	$	412.0	$	1,404.0	$	1,710.6	7	%	(18)	%

31

Employee compensation and benefits

Employee compensation and benefits increased by $11.3 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily driven by increases of $8.1 million in variable compensation mainly due to a higher annual bonus pool and other variable compensation. Variable compensation, including bonus pools, is generally calculated as a percentage of operating income excluding incentive compensation (pre-incentive operating income) and is allocated to employees by management on a discretionary basis. Also contributing to the increase in employee compensation and benefits was a $4.2 million increase in salary and benefits due to higher headcount driven by the conversion of temporary staff to full-time employees, annual and one-time base-pay increases of $3.2 million and unfavorable foreign currency translation of $2.5 million. These increases were partially offset by a $3.5 million decrease in temporary staffing charges due to the aforementioned conversion of temporary staff to full-time employees and a decrease of $3.2 million in project charges driven by more internal labor costs capitalized during the three months ended September 30, 2021.

Employee compensation and benefits increased by $76.9 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily driven by increases of $66.7 million in variable compensation, mainly due to a higher annual bonus pool and other variable compensation, unfavorable foreign currency translation of $15.3 million, a $9.2 million increase in salary and benefits due to higher headcount, and annual and one-time base-pay increases of $6.6 million. These increases were partially offset by a $11.1 million decrease in temporary staffing charges due to the conversion of temporary staff to full-time employees and a decrease of $9.8 million in project charges driven by more internal labor costs capitalized during the nine months ended September 30, 2021.

Long-term incentive plans

Long-term incentive plan expenses decreased $7.7 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily driven by a $6.0 million decrease in fair value adjustments related to mutual fund share awards and certain long-term incentive awards and a decrease of $2.4 million due to the roll-off of vested awards exceeding new awards during the three months ended September 30, 2021. These decreases were partially offset by unfavorable foreign currency translation of $0.7 million.

Long-term incentive plan expenses increased $12.9 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily driven by an $11.8 million increase in fair value adjustments related to mutual fund share awards and certain long-term incentive awards, unfavorable foreign currency translation of $4.6 million and $1.2 million in higher payroll taxes on vestings. These increases were partially offset by a decrease of $4.7 million due to the roll-off of vested awards exceeding new awards during the nine months ended September 30, 2021.

Distribution expenses

Distribution expenses are paid to financial intermediaries for the distribution and servicing of our retail investment products and are typically calculated based on the amount of the intermediary-sourced AUM. Distribution expenses increased $23.3 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily due to an increase of $21.1 million driven by an improvement in average AUM subject to distribution charges.

Distribution expenses increased $68.6 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily due to an increase of $70.3 million from an improvement in average AUM subject to distribution charges.

Marketing

Marketing expenses increased $2.2 million and $4.7 million during the three and nine months ended September 30, 2021, compared to the three and nine months ended September 30, 2020, respectively, primarily due to an increase in marketing events and advertising campaigns during the three and nine months ended September 30, 2021.

32

General, administrative and occupancy

General, administrative and occupancy expenses decreased by $0.1 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily due a $4.6 million decrease in consultancy fees related to certain project costs. This decrease was partially offset by a $2.2 million increase in information technology costs, primarily driven by software vendor servicing fees, unfavorable foreign currency translation of $1.2 million, a $1.1 million increase in travel and entertainment, and a $1.1 million increase in charitable contributions during the three months ended September 30, 2021.

General, administrative and occupancy expenses increased by $5.4 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily due to unfavorable foreign currency translation of $8.4 million and a $4.3 million increase in information technology costs, primarily related to software vendor servicing fees. These increases were partially offset by decreases of $7.6 million in consultancy fees related to certain project costs and $2.4 million in travel expenses as a result of reduced travel during the COVID-19 pandemic during the nine months ended September 30, 2021.

Impairment of goodwill and intangible assets

Goodwill and intangible asset impairment charges decreased by $469.3 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020. The decrease is primarily due to a $487.3 million impairment of our goodwill and certain mutual fund investment management agreements and client relationships, and a $26.4 million impairment of the VelocityShares ETN definite-lived intangible asset recognized during the nine months ended September 30, 2020. These decreases are partially offset by a $44.4 million impairment of certain indefinite-lived intangible assets, and the Perkins brand name, both recognized during the nine months ended September 30, 2021. During the first quarter of 2021, we completed a review of Perkins. To right-size our product portfolio and more closely align with the changing needs of clients, certain strategies were closed and the funds liquidated during the second quarter of 2021. The Perkins brand was discontinued, and marketing efforts for value equity strategies were incorporated under the Janus Henderson brand.

Depreciation and amortization

Depreciation and amortization expenses decreased by $1.8 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020, primarily due to a decrease in the depreciation of internally developed software.

Depreciation and amortization expenses decreased by $7.1 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, primarily due to a decrease in the amortization of intangible assets resulting from the sale of Geneva and the impairment of certain client relationships recognized during the nine months ended September 30, 2020, as well as a decrease in the depreciation of internally developed software recognized during the nine months ended September 30, 2021.

Non-Operating Income and Expenses

									Three months		Nine months
	Three months ended				Nine months ended				ended		ended
	September 30,				September 30,				September 30,		September 30,
	2021		2020		2021		2020		2021 vs. 2020		2021 vs. 2020
Non-operating income and expenses (in millions):
Interest expense	$	(3.2)	$	(3.2)	$	(9.6)	$	(9.7)	—	%	1	%
Investment gains, net		4.7		25.5		8.1		25.3	(82)	%	(68)	%
Other non-operating income (expenses), net		3.6		(0.9)		0.8		39.9	n/m	*	(98)	%
Income tax provision		(53.3)		(40.8)		(176.1)		(2.1)	31	%	n/m	*
* n/m - Not meaningful.

33

Investment gains, net

The components of investment gains, net for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

									Three months		Nine months
	Three months ended				Nine months ended				ended		ended
	September 30,				September 30,				September 30,		September 30,
	2021		2020		2021		2020		2021 vs. 2020		2021 vs. 2020
Investment gains, net (in millions):
Seeded investment products and hedges, net	$	1.4	$	5.2	$	4.4	$	11.2	(73)	%	(61)	%
Third-party ownership interests in seeded investment products		3.0		18.1		(1.1)		8.7	(83)	%	n/m	*
Long Tail Alpha equity method investment		0.2		0.4		2.1		6.1	(50)	%	(66)	%
Deferred equity plan		0.2		1.4		2.3		(1.2)	(86)	%	n/m	*
Other		(0.1)		0.4		0.4		0.5	n/m	*	(20)	%
Investment gains, net	$	4.7	$	25.5	$	8.1	$	25.3	(82)	%	(68)	%
* n/m - Not meaningful.

Investment gains, net moved unfavorably by $20.8 million and $17.2 million during the three and nine months ended September 30, 2021, compared to the three and nine months ended September 30, 2020, respectively. Movements in investment gains, net are primarily due to fair value adjustments in relation to our seeded investment products, deferred equity plan and consolidation of third-party ownership interests in seeded investment products.

Other non-operating income (expenses), net

Other non-operating income (expenses), net improved $4.5 million during the three months ended September 30, 2021, compared to the three months ended September 30, 2020 primarily due to favorable foreign currency translation of $4.4 million during the three months ended September 30, 2021.

Other non-operating income (expenses), net declined $39.1 million during the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020. The decrease was primarily due to a $16.2 million gain and $7.1 million contingent consideration adjustment in relation to the sale of Geneva recognized during the nine months ended September 30, 2020, and $16.3 million of unfavorable foreign currency translation when comparing the nine months ended September 30, 2021 to the nine months ended September 30, 2020.

Income tax (benefit) provision

Our effective tax rates for the three and nine months ended September 30, 2021 and 2020, were as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Effective tax rate	21.0	%	22.9	%	26.5	%	(15.3)	%

The change in the three months ended September 30, 2020 and the three months ended September 30, 2021 is primarily related to the enactment of Finance Act 2020, where the United Kingdom (“UK”) government announced the UK tax rate would remain at 19% and not reduce to 17% as scheduled, resulting in a deferred tax expense in the three months ended September 30, 2020.

34

The effective tax rate for the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was impacted by the enactment of Finance Act 2021 during the second quarter of 2021, which increased the UK corporation tax rate from 19% to 25% beginning in April 2023. As a result, the UK deferred tax assets and liabilities expected to be settled after 2023 were revalued from 19% to 25%, creating a non-cash deferred tax expense of $31.0 million. The effective tax rate for the nine months ended September 30, 2020, was also impacted by the enactment of Finance Act 2020, as discussed above. In addition, there were significant impairments of intangible assets and goodwill in the first quarter of 2020, which contributed to a pre-tax book loss for the nine months ended September 30, 2020. The majority of the impairment charges were related to temporary differences, which adjusted deferred income taxes and did not have a direct impact on the effective tax rate.

As of September 30, 2021, and December 31, 2020, we had $14.9 million and $15.8 million of unrecognized tax benefits held for uncertain tax positions, respectively. We estimate that the existing liability for uncertain tax positions could decrease by up to $0.6 million within the next 12 months, without giving effect to changes in foreign currency translation.

Net loss (income) attributable to noncontrolling interests

The components of net loss (income) attributable to noncontrolling interests for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

									Three months		Nine months
	Three months ended				Nine months ended				ended		ended
	September 30,				September 30,				September 30,		September 30,
	2021		2020		2021		2020		2021 vs. 2020		2021 vs. 2020
Net loss (income) attributable to noncontrolling interests (in millions):
Consolidated seeded investment products	$	(3.0)	$	(18.1)	$	1.1	$	(8.7)	83	%	n/m	*
Majority-owned subsidiaries		(0.3)		(0.1)		(0.5)		(0.7)	(200)	%	29	%
Total net loss (income) attributable to noncontrolling interests	$	(3.3)	$	(18.2)	$	0.6	$	(9.4)	82	%	n/m	*

* n/m - Not meaningful.

Net loss (income) attributable to noncontrolling interests improved by $14.9 million and $10.0 million during the three and nine months ended September 30, 2021, compared to the three and nine months ended September 30, 2020, respectively. The increase was primarily due to third-party ownership interests in consolidated seeded investment products and fair value adjustments in relation to our seeded investment products.

2021 Operating Expenses

The 2021 expectation for non-compensation operating expenses growth is now expected to be at the high end of the mid-single digits. The expectation for full year 2021 adjusted compensation to revenue ratio is now anticipated at the low end of the 40% to 42% range. The expectation for full year 2021 statutory tax rate is 23%-25%.

Non-GAAP Financial Measures

We report our financial results in accordance with GAAP. However, JHG management evaluates our profitability and our ongoing operations using additional non-GAAP financial measures. These measures are not in accordance with, or a substitute for, GAAP, and our financial measures may be different from non-GAAP financial measures used by other companies. Management uses these performance measures to evaluate the business, and adjusted values are consistent with internal management reporting. We have provided a reconciliation below of our non-GAAP financial measures to the most directly comparable GAAP measures.

35

Alternative performance measures

The following is a reconciliation of revenue, operating expenses, operating income, net income attributable to JHG and diluted earnings per share to adjusted revenue, adjusted operating expenses, adjusted operating income, adjusted net income attributable to JHG and adjusted diluted earnings per share, respectively, for the three months ended September 30, 2021 and 2020 (in millions, except per share and operating margin data):

	Three months ended		Three months ended
	September 30,		September 30,
	2021		2020
Reconciliation of revenue to adjusted revenue
Revenue	$	687.4	$	568.5
Management fees		(53.0)		(47.9)
Shareowner servicing fees		(55.4)		(42.8)
Other revenue		(33.7)		(28.1)
Adjusted revenue(1)	$	545.3	$	449.7
Reconciliation of operating expenses to adjusted operating expenses
Operating expenses	$	439.1	$	412.0
Employee compensation and benefits(2)		—		(0.3)
Long-term incentive plans(2)		0.1		0.1
Distribution expenses(1)		(142.1)		(118.8)
General, administrative and occupancy(2)		(2.9)		(3.5)
Depreciation and amortization(3)		(1.9)		(1.9)
Adjusted operating expenses	$	292.3	$	287.6
Adjusted operating income		253.0		162.1
Operating margin(4)		36.1%		27.5%
Adjusted operating margin(5)		46.4%		36.0%
Reconciliation of net income attributable to JHG to adjusted net income attributable to JHG
Net income (loss) attributable to JHG	$	196.8	$	118.9
Employee compensation and benefits(2)		—		0.3
Long-term incentive plans(2)		(0.1)		(0.1)
General, administrative and occupancy(2)		2.9		3.5
Depreciation and amortization(3)		1.9		1.9
Other non-operating income (expenses), net(6)		(1.6)		(0.5)
Income tax provision(7)		(0.4)		5.6
Adjusted net income attributable to JHG		199.5		129.6
Less: allocation of earnings to participating stock-based awards		(5.5)		(3.8)
Adjusted net income attributable to JHG common shareholders	$	194.0	$	125.8
Weighted-average common shares outstanding — diluted (two class)		167.8		178.8
Diluted earnings per share (two class)(8)	$	1.14	$	0.65
Adjusted diluted earnings per share (two class)(9)	$	1.16	$	0.70

36

(1) We contract with third-party intermediaries to distribute and service certain of our investment products. Fees for distribution and servicing related activities are either provided for separately in an investment product’s prospectus or are part of the management fee. Under both arrangements, the fees are collected by us and passed through to third-party intermediaries who are responsible for performing the applicable services. The majority of distribution and servicing fees we collect are passed through to third-party intermediaries. JHG management believes that the deduction of distribution and servicing fees from revenue in the computation of adjusted revenue reflects the pass-through nature of these revenues. In certain arrangements, we perform the distribution and servicing activities and retain the applicable fee. Revenues for distribution and servicing activities performed by us are not deducted from GAAP revenue.

(2) Adjustments primarily represent rent expense for subleased office space. In addition, the adjustment for the three months ended September 30, 2021, includes a one-time charge related to the employee benefits trust. JHG management believes these costs do not represent our ongoing operations.

(3) Investment management contracts have been identified as a separately identifiable intangible asset arising on the acquisition of subsidiaries and businesses. Such contracts are recognized at the net present value of the expected future cash flows arising from the contracts at the date of acquisition. For segregated mandate contracts, the intangible asset is amortized on a straight-line basis over the expected life of the contracts. JHG management believes these non-cash and acquisition-related costs are not representative of our ongoing operations.

(4) Operating margin is operating income divided by revenue.

(5) Adjusted operating margin is adjusted operating income divided by adjusted revenue.

(6) Adjustments primarily relate to contingent consideration adjustments associated with prior acquisitions. JHG management believes these costs are not representative of our ongoing operations.

(7) The tax impact of the adjustments is calculated based on the applicable U.S. or foreign statutory tax rate as it relates to each adjustment. Certain adjustments are either not taxable or not tax-deductible.

(8) Diluted earnings per share is net income attributable to JHG common shareholders divided by weighted-average diluted common shares outstanding.

(9) Adjusted diluted earnings per share is adjusted net income attributable to JHG common shareholders divided by weighted-average diluted common shares outstanding.

LIQUIDITY AND CAPITAL RESOURCES

Our capital structure, together with available cash balances, cash flows generated from operations, and further capital and credit market activities, if necessary, should provide us with sufficient resources to meet present and future cash needs, including operating and other obligations as they fall due and anticipated future capital requirements.

The following table summarizes key balance sheet data relating to our liquidity and capital resources as of September 30, 2021, and December 31, 2020 (in millions):

	September 30,		December 31,
	2021		2020
Cash and cash equivalents held by the Company	$	930.8	$	1,096.9
Investment securities held by the Company	$	265.9	$	238.8
Fees and other receivables	$	359.5	$	373.6
Debt	$	311.1	$	313.3

37

Cash and cash equivalents consist primarily of cash at banks and in money market funds. Cash and cash equivalents and investment securities held by consolidated VIEs and VREs are not available for general corporate purposes and have been excluded from the table above.

Investment securities held by us represent seeded investment products (exclusive of investments held by consolidated VIEs and VREs), investments related to deferred compensation plans and other less significant investments.

We believe that existing cash and cash from operations should be sufficient to satisfy our short-term capital requirements. Expected short-term uses of cash include ordinary operating expenditures, seed capital investments, interest expense, dividend payments, income tax payments and common stock repurchases. We may also use available cash for other general corporate purposes and acquisitions.

Regulatory Capital

We are subject to regulatory oversight by the SEC, the Financial Industry Regulatory Authority (“FINRA”), the U.S. Commodity Futures Trading Commission (“CFTC”), the Financial Conduct Authority (“FCA”) and other international regulatory bodies. We strive to ensure that we are compliant with our regulatory obligations at all times. Our primary capital requirement relates to the FCA-supervised regulatory group (a sub-group of our company), comprising Janus Henderson (UK) Holdings Limited, all of its subsidiaries and Janus Capital International Limited (“JCIL”). JCIL is included to meet the requirements of certain regulations under the Banking Consolidation Directive. The combined capital requirement is £198.4 million ($267.5 million), resulting in £284.0 million ($383.0 million) of capital above the requirement as of September 30, 2021, based on internal calculations and taking into account the effect of dividends related to third quarter 2021 results that will be paid in the fourth quarter 2021. Capital requirements in other jurisdictions are not significant.

Short-Term Liquidity and Capital Resources

Common Stock Repurchases

On July 28, 2021, the Board approved a new on-market share buyback program (“2021 Corporate Buyback Program”) pursuant to which we are authorized to repurchase up to $200.0 million of our common stock on the NYSE and CDIs on the Australian Securities Exchange (“ASX”) at any time prior to the date of our 2022 Annual General Meeting. We commenced repurchases under the 2021 Corporate Buyback Program in August 2021, and during the three months ended September 30, 2021 we repurchased 1,765,459 shares of our common stock and CDIs for $75.0 million.

On February 3, 2020, the Board approved an on-market share buyback program pursuant to which we were authorized to repurchase up to $200.0 million of our common stock on the NYSE and CDIs on the ASX at any time prior to the date of our 2021 Annual General Meeting (the “2020 Corporate Buyback Program”). We commenced repurchases under the 2020 Corporate Buyback Program in March 2020, and during the first quarter of 2021, we repurchased 4,827 shares of our common stock and CDIs for $0.2 million related to the 2020 Corporate Buyback Program. We terminated the 2020 Corporate Buyback Program on February 9, 2021, following completion of the Block Repurchase described below.

On February 4, 2021, Dai-ichi Life announced its intention to sell all 30,668,922 shares of JHG common stock it owned by means of a registered secondary public offering. On February 9, 2021, Dai-ichi Life completed the secondary offering and as part of the offering, we repurchased 8,048,360 shares of common stock from Dai-ichi Life (the “Block Repurchase”) for approximately $230.0 million through Goldman Sachs & Co. LLC (“as underwriter”) at the price at which the shares of common stock were sold to the public in the secondary offering, less the underwriting discount. The Block Repurchase was authorized by the Board and is distinct from the 2020 Corporate Buyback Program. We did not receive any proceeds from Dai-ichi Life’s sale of common stock in the secondary offering.

Some of our executives and employees obtain rights to receive our common stock as part of their remuneration arrangements and employee entitlements. We usually satisfy these entitlements by transferring shares of common stock that we repurchase on-market for this purpose. We purchased 5,869 shares at an average price of $42.35 in satisfaction of employee awards and entitlements during the three months ended September 30, 2021.

38

Dividends

The payment of cash dividends is within the discretion of our Board of Directors and depends on many factors, including our results of operations, financial condition, capital requirements, general business conditions and legal requirements.

Dividends declared and paid during the nine months ended September 30, 2021, were as follows:

Dividend		Date	Dividends paid		Date
per share		declared	(in US$ millions)		paid
$	0.36	February 3, 2021	$	61.7	March 3, 2021
$	0.38	April 28, 2021	$	65.0	May 27, 2021
$	0.38	July 28, 2021	$	64.8	August 25, 2021

On October 27, 2021, our Board of Directors declared a cash dividend of $0.38 per share. The quarterly dividend will be paid on November 24, 2021, to shareholders of record at the close of business on November 8, 2021.

Long-Term Liquidity and Capital Resources

Expected long-term commitments as of September 30, 2021, include principal and interest payments related to the 2025 Senior Notes, operating and finance lease payments, Intech senior profits interests awards, Intech appreciation rights and phantom interests, and Intech noncontrolling interests. We expect to fund our long-term commitments with existing cash and cash generated from operations or by accessing capital and credit markets as necessary.

2025 Senior Notes

The 2025 Senior Notes have a principal amount of $300.0 million, pay interest at 4.875% semiannually on February 1 and August 1 of each year, and mature on August 1, 2025.

Intech

Intech has granted long-term incentive awards to retain and incentivize employees. The awards consist of appreciation rights, profits interests and phantom interests, and are designed to give recipients an equity-like stake in Intech. The grant date fair value of the appreciation rights is amortized using a graded basis over the 10-year vesting period. The awards are exercisable upon termination of employment from Intech to the extent vested. The profits interests and phantom interests awards entitle recipients to 9.0% of Intech’s pre-incentive profits.

Defined Benefit Pension Plan

The latest triennial valuation of our defined benefit pension plan resulted in a surplus of $16.2 million. An update to the triennial valuation is underway and is expected to be completed in the fourth quarter of 2021.

Off-Balance Sheet Arrangements

We are not party to any off-balance sheet arrangements that may provide, or require us to provide, financing, liquidity, market or credit risk support that are not reflected in our condensed consolidated financial statements.

Other Sources of Liquidity

At September 30, 2021, we had a $200 million Credit Facility. The Credit Facility includes an option for us to request an increase to our borrowing capacity under the Credit Facility of up to an additional $50.0 million. The maturity date of the Credit Facility is February 16, 2024.

The Credit Facility may be used for general corporate purposes and bears interest on borrowings outstanding at the relevant interbank offer rate plus a spread.

39

The Credit Facility contains a financial covenant with respect to leverage. The financing leverage ratio cannot exceed 3.00x EBITDA. At the latest practicable date before the date of this report, we were in compliance with all covenants, and there were no outstanding borrowings under the Credit Facility.

Cash Flows

Cash flow data for the nine months ended September 30, 2021 and 2020, was as follows (in millions):

	Nine months ended
	September 30,
	2021		2020
Cash flows provided by (used for):
Operating activities	$	614.2	$	425.5
Investing activities		(265.8)		10.0
Financing activities		(497.4)		(299.8)
Effect of exchange rate changes on cash and cash equivalents		(14.5)		(5.7)
Net change in cash and cash equivalents		(163.5)		130.0
Cash balance at beginning of period		1,108.1		796.5
Cash balance at end of period	$	944.6	$	926.5

Operating Activities

Fluctuations in operating cash flows are attributable to changes in net income and working capital items, which can vary from period to period based on the amount and timing of cash receipts and payments.

Investing Activities

Cash (used for) provided by investing activities for the nine months ended September 30, 2021 and 2020, was as follows (in millions):

	Nine months ended
	September 30,
	2021		2020
(Purchases) sales of investment securities, net	$	(196.5)	$	48.8
Purchases of investment securities by consolidated seeded investment products, net		(58.0)		(64.8)
Purchase of property, equipment and software		(5.9)		(16.5)
Proceeds from sale of Geneva		—		38.4
Cash paid on settled hedges, net		(12.6)		(0.1)
Other		7.2		4.2
Cash (used for) provided by investing activities	$	(265.8)	$	10.0

Cash outflows from investing activities were $265.8 million during the nine months ended September 30, 2021, and cash inflows from investing activities were $10.0 million during the nine months ended September 30, 2020. Cash outflows from investing activities during the nine months ended September 30, 2021, were primarily due to net purchases of investment securities and net purchases of investment securities by consolidated seeded investment products. When comparing the nine months ended September 30, 2021, to the nine months ended September 30, 2020, the change in cash (used for) provided by investing activities was primarily due to increases in the purchase of investment securities and net cash paid to settle hedges related to our seed capital hedge program. These increases were partially offset by proceeds from the sale of Geneva recognized during the nine months ended September 30, 2020.

40

Financing Activities

Cash used for financing activities for the nine months ended September 30, 2021 and 2020, was as follows (in millions):

	Nine months ended
	September 30,
	2021		2020
Dividends paid to shareholders	$	(191.5)	$	(198.1)
Third-party sales in consolidated seeded investment products, net		61.2		64.8
Purchase of common stock for stock-based compensation plans		(72.1)		(48.4)
Purchase of common stock from Dai-ichi and share buyback program		(305.2)		(103.4)
Payment of contingent consideration		—		(13.8)
Proceeds from stock-based compensation plans		10.9		—
Other		(0.7)		(0.9)
Cash used for financing activities	$	(497.4)	$	(299.8)

Cash outflows from financing activities were $497.4 million and $299.8 million during the nine months ended September 30, 2021 and 2020, respectively. Cash outflows from financing activities during the nine months ended September 30, 2021, were primarily due to the purchase of common stock from Dai-ichi Life, the share buyback program and stock-based compensation plans and dividends paid to shareholders, partially offset by net sales of investment securities within consolidated seeded investment products. When comparing the nine months ended September 30, 2021, to the nine months ended September 30, 2020, the change in cash used for financing activities was primarily due to the purchase of common stock from Dai-ichi Life and the purchase of common stock for stock-based compensation plans.

Item 3.   Quantitative and Qualitative Disclosures About Market Risk

There were no material changes in our exposure to market risks from that previously reported in our Annual Report on Form 10-K for the year ended December 31, 2020.

Item 4.   Controls and Procedures

As of September 30, 2021, our management evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act). Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by us in the reports that we file or submit under the Exchange Act is accumulated and communicated to our management, including our principal executive and principal financial officers, or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure. Disclosure controls and procedures are designed by us to ensure that we record, process, summarize and report within the time periods specified in the SEC’s rule and forms the information we must disclose in reports that we file with or submit to the SEC. Richard M. Weil, our CEO, and Roger Thompson, our Chief Financial Officer, reviewed and participated in management’s evaluation of the disclosure controls and procedures. Based on this evaluation, Mr. Weil and Mr. Thompson concluded that as of the date of their evaluation, our disclosure controls and procedures were effective.

There were no changes in our internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the third quarter of 2021 that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

Item 1.    Legal Proceedings

See Part I, Item 1. Financial Statements, Note 14 — Commitments and Contingencies.

41

Item 2.    Unregistered Sales of Equity Securities and Use of Proceeds

Common Stock Purchases

On July 28, 2021, the Board approved the 2021 Corporate Buyback Program pursuant to which we are authorized to repurchase up to $200.0 million of our common stock on the NYSE and CDIs on the ASX at any time prior to the date of our 2022 Annual General Meeting. We commenced repurchases under the 2021 Corporate Buyback Program in August 2021, and during the three months ended September 30, 2021, we repurchased 1,765,459 shares of our common stock and CDIs for $75.0 million.

On February 3, 2020, the Board approved the 2020 Corporate Buyback Program, pursuant to which we were authorized to repurchase up to $200.0 million of our common stock on the NYSE and CDIs on the ASX at any time prior to the date of our 2021 Annual General Meeting. We commenced repurchases under the 2020 Corporate Buyback Program in March 2020, and during the first quarter of 2021, we repurchased 4,827 shares of our common stock and CDIs for $0.2 million related to the 2020 Corporate Buyback Program. We terminated the 2020 Corporate Buyback Program on February 9, 2021, following completion of the Block Repurchase described below.

On February 4, 2021, Dai-ichi Life announced its intention to sell all 30,668,922 shares of JHG common stock it owned by means of a registered secondary public offering. On February 9, 2021, Dai-ichi Life completed the secondary offering and as part of the offering, we repurchased 8,048,360 shares of common stock from Dai-ichi Life in the Block Repurchase for approximately $230.0 million through Goldman Sachs & Co. LLC as underwriter at the price at which the shares of common stock were sold to the public in the secondary offering, less the underwriting discount. The Block Repurchase was authorized by the Board and is distinct from the 2020 Corporate Buyback Program. We did not receive any proceeds from Dai-ichi Life’s sale of common stock in the secondary offering.

Some of our executives and employees obtain rights to receive our common stock as part of their remuneration arrangements and employee entitlements. We usually satisfy these entitlements by transferring shares of existing common stock that we repurchase on-market for this purpose (“Share Plans Repurchases”). During the third quarter 2021, we purchased 5,869 shares on-market for $0.2 million in satisfaction of employee awards and entitlements.

42

The following is a summary of our common stock repurchases by month during the nine months ended September 30, 2021, including repurchases under the 2021 and 2020 Corporate Buyback Programs and Share Plans Repurchases.

	Total			Total number of shares	Approximate U.S. dollar value
	number of	Average		purchased as part of	of shares that may yet
	shares	price paid per		publicly announced	be purchased under the
Period	purchased	share		programs	programs (end of month, in millions)
January 1, 2021, through January 31, 2021	2,479	$	32.14	—	$	69
February 1, 2021, through February 28, 2021	9,819,360		28.80	4,827	$	—
March 1, 2021, through March 31, 2021	342,268		30.12	—	$	—
April 1, 2021, through April 30, 2021	2,764		34.31	—	$	—
May 1, 2021, through May 31, 2021	25,292		37.24	—	$	—
June 1, 2021, through June 30, 2021	252,436		38.88	—	$	—
July 1, 2021, through July 31, 2021	2,155		42.09	—	$	200
August 1, 2021, through August 31, 2021	865,452		42.63	863,881	$	163
September 1, 2021, through September 30, 2021	903,721		42.41	901,578	$	125
Total	12,215,927	$	31.05	1,770,286

Items 3, 4 and 5.

Not applicable.

43

Item 6.    Exhibits

Filed with this Report:

Exhibit No.	Document	Regulation S-K Item 601(b) Exhibit No.
15.1	Letter regarding unaudited interim financial information	15
31.1	Certification of Richard M. Weil, Chief Executive Officer of Registrant	31
31.2	Certification of Roger Thompson, Chief Financial Officer of Registrant	31
32.1	Certification of Richard M. Weil, Chief Executive Officer of Registrant, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	32
32.2	Certification of Roger Thompson, Chief Financial Officer of Registrant, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002	32
101.INS	XBRL Instance Document — the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document	101
101.SCH	XBRL Taxonomy Extension Schema Document	101
101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document	101
101.DEF	XBRL Taxonomy Extension Definition Linkbase Document	101
101.LAB	XBRL Taxonomy Extension Label Linkbase Document	101
101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document	101
104	Cover Page Interactive Data File (the cover page XBRL tags are embedded in the Inline XBRL document)	104

44

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: October 28, 2021

Janus Henderson Group plc

/s/ Richard Weil

Richard Weil,

Director and Chief Executive Officer

(Principal Executive Officer)

/s/ Roger Thompson

Roger Thompson,

Chief Financial Officer

(Principal Financial Officer)

/s/ Brennan Hughes

Brennan Hughes,

Chief Accounting Officer and Treasurer

(Principal Accounting Officer)

45

EX-15.1

Exhibit 15.1

October 28, 2021

Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

Commissioners:

We are aware that our report dated October 28, 2021 on our review of interim financial information of Janus Henderson Group plc, which appears in this Quarterly Report on Form 10-Q, is incorporated by reference in the Registration Statements on Form S-3 (No. 333-252714) and Form S-8 (Nos. 333-218365 and 333-236685) of Janus Henderson Group plc.

Very truly yours,

/s/PricewaterhouseCoopers LLP

Denver, Colorado

EX-31.1

Exhibit 31.1

CERTIFICATION

I, Richard Weil, certify that:

1.            I have reviewed this quarterly report on Form 10-Q of Janus Henderson Group plc;

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)            Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.           The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Richard Weil

Richard Weil

Chief Executive Officer

Date: October 28, 2021

A signed original of this written statement required by Section 302 has been provided to Janus Henderson Group plc and will be retained by Janus Henderson Group plc and furnished to the Securities and Exchange Commission or its staff upon request.

EX-31.2

Exhibit 31.2

CERTIFICATION

I, Roger Thompson, certify that:

1.            I have reviewed this quarterly report on Form 10-Q of Janus Henderson Group plc;

2.            Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.            Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.            The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)            Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)           Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)            Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)           Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.            The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)            All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting that are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)           Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Roger Thompson

Roger Thompson

Chief Financial Officer

Date: October 28, 2021

A signed original of this written statement required by Section 302 has been provided to Janus Henderson Group plc and will be retained by Janus Henderson Group plc and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.1

Exhibit 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Janus Henderson Group plc on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Richard Weil, Chief Executive Officer of Janus Henderson Group plc, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.           The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.            The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of Janus Henderson Group plc.

/s/ Richard Weil

Richard Weil

Chief Executive Officer

Date: October 28, 2021

A signed original of this written statement required by Section 906 has been provided to Janus Henderson Group plc and will be retained by Janus Henderson Group plc and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report of Janus Henderson Group plc on Form 10-Q for the quarter ended September 30, 2021, as filed with the Securities and Exchange Commission on the date hereof (the “report”), I, Roger Thompson, Chief Financial Officer of Janus Henderson Group plc, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

1.           The report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2.            The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of Janus Henderson Group plc.

/s/ Roger Thompson

Roger Thompson

Chief Financial Officer

Date: October 28, 2021

A signed original of this written statement required by Section 906 has been provided to Janus Henderson Group plc and will be retained by Janus Henderson Group plc and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2021	Oct. 25, 2021
Document and Entity Information
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2021
Document Transition Report	false
Entity File Number	001-38103
Entity Registrant Name	JANUS HENDERSON GROUP PLC
Entity Incorporation, State or Country Code	Y9
Entity Tax Identification Number	98-1376360
Entity Address, Address Line One	201 Bishopsgate
Entity Address, City or Town	London
Entity Address, Country	GB
Entity Address, Postal Zip Code	EC2M3AE
Country Region	+44
City Area Code	(0) 20
Local Phone Number	7818 1818
Title of 12(b) Security	Common Stock, $1.50 Per Share Par Value
Trading Symbol	JHG
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		170,584,530
Entity Central Index Key	0001274173
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q3
Amendment Flag	false

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Current assets:
Fees and other receivables	$ 359.5	$ 373.6
OEIC and unit trust receivables	180.7	114.7
Total current assets	2,299.3	2,193.7
Non-current assets:
Property, equipment and software, net	63.7	77.9
Intangible assets, net	2,620.9	2,686.3
Goodwill	1,370.8	1,383.9
Retirement benefit asset, net	189.8	191.3
Other non-current assets	158.7	157.7
Total assets	6,703.2	6,690.8
Current liabilities:
Current portion of accrued compensation, benefits and staff costs	351.0	371.0
OEIC and unit trust payables	189.6	121.5
Total current liabilities	772.9	727.8
Non-current liabilities:
Accrued compensation, benefits and staff costs	36.9	53.7
Long-term debt	311.1	313.3
Deferred tax liabilities, net	644.7	627.4
Retirement benefit obligations, net	4.7	4.7
Other non-current liabilities	125.6	144.3
Total liabilities	1,895.9	1,871.2
Commitments and contingencies (See Note 14)
REDEEMABLE NONCONTROLLING INTERESTS	145.1	85.8
EQUITY
Common stock, $1.50 par value; 480,000,000 shares authorized, and 170,584,530 and 180,403,176 shares issued and outstanding as of September 30, 2021, and December 31, 2020, respectively	255.9	270.6
Additional paid-in-capital	3,755.4	3,815.0
Treasury shares, X,XXX,XXX and 2,548,063 shares held at September 30, 2021, and December 31, 2020, respectively	(58.1)	(107.3)
Accumulated other comprehensive loss, net of tax	(376.9)	(324.0)
Retained earnings	1,070.3	1,062.1
Total shareholders' equity	4,646.6	4,716.4
Nonredeemable noncontrolling interests	15.6	17.4
Total equity	4,662.2	4,733.8
Total liabilities, redeemable noncontrolling interests and equity	6,703.2	6,690.8
Consolidated excluding VIEs
Current assets:
Cash and cash equivalents	933.1	1,099.7
Investment securities	445.2	268.1
Other current assets	122.0	111.1
Current liabilities:
Accounts payable and accrued liabilities	229.4	232.1
Consolidated VIEs
Current assets:
Cash and cash equivalents	11.5	8.4
Investment securities	245.3	214.6
Other current assets	2.0	3.5
Current liabilities:
Accounts payable and accrued liabilities	$ 2.9	$ 3.2

XML

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED) (Parenthetical) - $ / shares	Sep. 30, 2021	Dec. 31, 2020
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
Par value	$ 1.50	$ 1.50
Common stock, shares authorized	480,000,000	480,000,000
Common stock, shares issued	170,584,530	180,403,176
Common stock, shares outstanding	170,584,530	180,403,176
Treasury shares (in shares)	1,208,917	2,548,063

XML

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (UNAUDITED) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Revenue:
Total revenue	$ 687.4	$ 568.5	$ 2,069.8	$ 1,641.4
Operating expenses:
Employee compensation and benefits	166.2	154.9	533.2	456.3
Long-term incentive plans	35.0	42.7	138.3	125.4
Distribution expenses	142.1	118.8	404.3	335.7
Investment administration	13.0	13.1	38.7	37.4
Marketing	7.5	5.3	20.4	15.7
General, administrative and occupancy	65.5	65.6	194.2	188.8
Impairment of goodwill and intangible assets			44.4	513.7
Depreciation and amortization	9.8	11.6	30.5	37.6
Total operating expenses	439.1	412.0	1,404.0	1,710.6
Operating income (loss)	248.3	156.5	665.8	(69.2)
Interest expense	(3.2)	(3.2)	(9.6)	(9.7)
Investment gains, net	4.7	25.5	8.1	25.3
Other non-operating income (expenses), net	3.6	(0.9)	0.8	39.9
Income (loss) before taxes	253.4	177.9	665.1	(13.7)
Income tax benefit (provision)	(53.3)	(40.8)	(176.1)	(2.1)
Net income (loss)	200.1	137.1	489.0	(15.8)
Net loss (income) attributable to noncontrolling interests	(3.3)	(18.2)	0.6	(9.4)
Net income (loss) attributable to JHG	$ 196.8	$ 118.9	$ 489.6	$ (25.2)
Earnings (loss) per share attributable to JHG common shareholders:
Basic	$ 1.15	$ 0.65	$ 2.82	$ (0.14)
Diluted	$ 1.14	$ 0.65	$ 2.81	$ (0.14)
Other comprehensive income (loss), net of tax:
Foreign currency translation gains (losses)	$ (59.6)	$ 97.4	$ (53.1)	$ (41.1)
Actuarial gains	0.1	0.1	0.4	0.3
Other comprehensive income (loss), net of tax	(59.5)	97.5	(52.7)	(40.8)
Other comprehensive loss (income) attributable to noncontrolling interests	0.8	(11.0)	(0.2)	(7.3)
Other comprehensive income (loss) attributable to JHG	(58.7)	86.5	(52.9)	(48.1)
Total comprehensive income (loss)	140.6	234.6	436.3	(56.6)
Total comprehensive loss (income) attributable to noncontrolling interests	(2.5)	(29.2)	0.4	(16.7)
Total comprehensive income (loss) attributable to JHG	138.1	205.4	436.7	(73.3)
Management fees
Revenue:
Total revenue	564.5	457.7	1,623.5	1,305.0
Performance fees
Revenue:
Total revenue	0.6	7.0	95.0	38.8
Shareowner servicing fees
Revenue:
Total revenue	67.6	53.7	192.4	151.3
Other revenue
Revenue:
Total revenue	$ 54.7	$ 50.1	$ 158.9	$ 146.3

XML

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020
Operating activities:
Net income (loss)	$ 489.0	$ (15.8)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	30.5	37.6
Impairment of goodwill and intangible assets	44.4	513.7
Deferred income taxes	24.2	(109.8)
Stock-based compensation plan expense	50.7	52.2
Impairment of right-of-use operating asset		1.3
Gain on sale of Geneva		(16.2)
Investment (gains) losses, net	(8.1)	(25.3)
Contributions to pension plans in excess of costs recognized	(1.0)	(0.4)
Contingent consideration fair value adjustment		(7.1)
Other, net	(7.4)	(14.7)
Changes in operating assets and liabilities:
OEIC and unit trust receivables and payables	2.1	8.5
Other assets	(14.0)	54.9
Other accruals and liabilities	3.8	(53.4)
Net operating activities	614.2	425.5
Sales (purchases) of:
Investment securities, net	(196.5)	48.8
Property, equipment and software	(5.9)	(16.5)
Investment securities by consolidated seeded investment products, net	(58.0)	(64.8)
Cash received (paid) on settled seed capital hedges, net	(12.6)	(0.1)
Dividends received from equity-method investments	1.1	0.4
Receipt of contingent consideration payments from sale of Volantis	0.7	2.2
Receipt of contingent consideration payments from sale of Geneva	5.4	1.6
Proceeds from sale of Geneva		38.4
Net investing activities	(265.8)	10.0
Financing activities:
Proceeds from stock-based compensation plans	10.9	(0.1)
Purchase of common stock for stock-based compensation plans	(72.1)	(48.4)
Purchase of common stock from Dai-ichi Life and share buyback program	(305.2)	(103.4)
Dividends paid to shareholders	(191.5)	(198.1)
Payment of contingent consideration		(13.8)
Distributions to noncontrolling interests	(0.4)	(0.5)
Third-party sales in consolidated seeded investment products, net	61.2	64.8
Principal payments under capital lease obligations	(0.3)	(0.3)
Net financing activities	(497.4)	(299.8)
Cash and cash equivalents:
Effect of foreign exchange rate changes	(14.5)	(5.7)
Net change	(163.5)	130.0
At beginning of period	1,108.1	796.5
At end of period	944.6	926.5
Supplemental cash flow information:
Cash paid for interest	14.6	14.6
Cash paid for income taxes, net of refunds	169.2	130.6
Reconciliation of cash and cash equivalents:
Cash and cash equivalents	944.6	926.5
Consolidated VIEs
Cash and cash equivalents:
At end of period	11.5	17.5
Reconciliation of cash and cash equivalents:
Cash and cash equivalents	11.5	17.5
Consolidated excluding VIEs
Cash and cash equivalents:
At end of period	933.1	909.0
Reconciliation of cash and cash equivalents:
Cash and cash equivalents	$ 933.1	$ 909.0

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($) $ in Millions	Common stock	Additional paid-in-capital	Treasury shares	Accumulated other comprehensive loss	Retained earnings	Nonredeemable noncontrolling interests	Total
Balance at Dec. 31, 2019	$ 280.5	$ 3,828.5	$ (139.5)	$ (367.1)	$ 1,284.1	$ 19.7	$ 4,906.2
Balance (in shares) at Dec. 31, 2019	187,000,000.0
Increase (Decrease) in Stockholders' Equity
Net income (loss)					(25.2)	(1.6)	(26.8)
Other comprehensive income (loss)				(48.1)			(48.1)
Dividends paid to shareholders		0.1			(198.2)		(198.1)
Purchase of common stock from Dai-ichi Life and/or share buyback program	$ (8.4)				(95.0)		(103.4)
Purchase of common stock from Dai-ichi Life and/or share buyback program (in shares)	(5,600,000)
Distributions to noncontrolling interests						(0.5)	(0.5)
Fair value adjustments to redeemable noncontrolling interests					0.1		0.1
Purchase of common stock for stock-based compensation plans		(44.9)	(3.5)				(48.4)
Vesting of stock-based compensation plans		(31.8)	31.8
Stock-based compensation plan expense		52.2					52.2
Proceeds from stock-based compensation plans		(0.1)					(0.1)
Balance at Sep. 30, 2020	$ 272.1	3,804.0	(111.2)	(415.2)	965.8	17.6	4,533.1
Balance (in shares) at Sep. 30, 2020	181,400,000
Balance at Jun. 30, 2020	$ 275.8	3,792.1	(114.6)	(501.7)	959.2	18.1	4,428.9
Balance (in shares) at Jun. 30, 2020	183,900,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)					118.9	(0.5)	118.4
Other comprehensive income (loss)				86.5			86.5
Dividends paid to shareholders					(65.5)		(65.5)
Purchase of common stock from Dai-ichi Life and/or share buyback program	$ (3.7)				(46.5)		(50.2)
Purchase of common stock from Dai-ichi Life and/or share buyback program (in shares)	(2,500,000)
Fair value adjustments to redeemable noncontrolling interests					(0.3)		(0.3)
Purchase of common stock for stock-based compensation plans		(2.1)	(0.6)				(2.7)
Vesting of stock-based compensation plans		(4.0)	4.0
Stock-based compensation plan expense		18.1					18.1
Proceeds from stock-based compensation plans		(0.1)					(0.1)
Balance at Sep. 30, 2020	$ 272.1	3,804.0	(111.2)	(415.2)	965.8	17.6	4,533.1
Balance (in shares) at Sep. 30, 2020	181,400,000
Balance at Dec. 31, 2020	$ 270.6	3,815.0	(107.3)	(324.0)	1,062.1	17.4	$ 4,733.8
Balance (in shares) at Dec. 31, 2020	180,400,000						180,403,176
Increase (Decrease) in Stockholders' Equity
Net income (loss)					489.6	(1.4)	$ 488.2
Other comprehensive income (loss)				(52.9)			(52.9)
Dividends paid to shareholders		0.1			(191.6)		(191.5)
Purchase of common stock from Dai-ichi Life and/or share buyback program	$ (14.7)				(290.5)		(305.2)
Purchase of common stock from Dai-ichi Life and/or share buyback program (in shares)	(9,800,000)
Distributions to noncontrolling interests						(0.4)	(0.4)
Fair value adjustments to redeemable noncontrolling interests					0.7		0.7
Purchase of common stock for stock-based compensation plans		(70.9)	(1.2)				(72.1)
Vesting of stock-based compensation plans		(50.4)	50.4
Stock-based compensation plan expense		50.7					50.7
Proceeds from stock-based compensation plans		10.9					10.9
Balance at Sep. 30, 2021	$ 255.9	3,755.4	(58.1)	(376.9)	1,070.3	15.6	$ 4,662.2
Balance (in shares) at Sep. 30, 2021	170,600,000						170,584,530
Balance at Jun. 30, 2021	$ 258.5	3,743.6	(67.6)	(318.2)	1,009.7	15.6	$ 4,641.6
Balance (in shares) at Jun. 30, 2021	172,300,000
Increase (Decrease) in Stockholders' Equity
Net income (loss)					196.8	0.1	196.9
Other comprehensive income (loss)				(58.7)			(58.7)
Dividends paid to shareholders					(64.8)		(64.8)
Purchase of common stock from Dai-ichi Life and/or share buyback program	$ (2.6)				(72.4)		(75.0)
Purchase of common stock from Dai-ichi Life and/or share buyback program (in shares)	(1,700,000)
Distributions to noncontrolling interests						(0.1)	(0.1)
Fair value adjustments to redeemable noncontrolling interests					1.0		1.0
Purchase of common stock for stock-based compensation plans		0.5	(0.6)				(0.1)
Vesting of stock-based compensation plans		(10.1)	10.1
Stock-based compensation plan expense		16.0					16.0
Proceeds from stock-based compensation plans		5.4					5.4
Balance at Sep. 30, 2021	$ 255.9	$ 3,755.4	$ (58.1)	$ (376.9)	$ 1,070.3	$ 15.6	$ 4,662.2
Balance (in shares) at Sep. 30, 2021	170,600,000						170,584,530

XML

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (Parenthetical) - $ / shares	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (UNAUDITED)
Dividends paid (per share)	$ 0.38	$ 0.36	$ 1.12	$ 1.08

XML

Basis of Presentation and Significant Accounting Policies

9 Months Ended

Sep. 30, 2021

Basis of Presentation and Significant Accounting Policies

Basis of Presentation and Significant Accounting Policies

Note 1 — Basis of Presentation and Significant Accounting Policies

Basis of Presentation

In the opinion of management of Janus Henderson Group plc (“JHG,” “the Company,” “we,” “us,” “our” and similar terms), the accompanying unaudited condensed consolidated financial statements contain all normal recurring adjustments necessary to fairly state our financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Such financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP are not required for interim reporting purposes and have been condensed or omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the annual consolidated financial statements and notes presented in our Annual Report on Form 10-K for the year ended December 31, 2020. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying financial statements through the issuance date.

Recent Accounting Pronouncements Adopted

Income Taxes

In December 2019, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s initiative to reduce complexity in accounting standards. The ASU eliminates certain exceptions to the general principles of ASC 740, Income Taxes, and simplifies income tax accounting in several areas. We adopted the ASU, which was effective as of January 1, 2021. The adoption of this ASU did not have a material impact on our results of operations or financial position.

XML

Consolidation

9 Months Ended

Sep. 30, 2021

Consolidation

Consolidation

Note 2 — Consolidation

Variable Interest Entities

Consolidated Variable Interest Entities

Our consolidated variable interest entities (“VIEs”) as of September 30, 2021, and December 31, 2020, include certain consolidated seeded investment products in which we have an investment and act as the investment manager. The assets of these VIEs are not available to us or our creditors. We may not, under any circumstances, access cash, cash equivalents or other assets held by consolidated VIEs to use in our operating activities or otherwise. In addition, the investors in these VIEs have no recourse to the credit of JHG.

Unconsolidated Variable Interest Entities

The following table presents the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VIEs (in millions):

	September 30,		December 31,
	2021		2020
Unconsolidated VIEs	$	99.8	$	9.6

Our total exposure to unconsolidated VIEs represents the value of our economic ownership interest in the investment securities.

Voting Rights Entities

Consolidated Voting Rights Entities

The following table presents the balances related to consolidated voting rights entities (“VREs”) that were recorded on our Condensed Consolidated Balance Sheets, including our net interest in these products (in millions):

	September 30,		December 31,
	2021		2020
Investment securities	$	179.3	$	29.3
Cash and cash equivalents		2.3		2.8
Other current assets		0.8		0.4
Accounts payable and accrued liabilities		(0.9)		(0.1)
Total	$	181.5	$	32.4
Redeemable noncontrolling interests in consolidated VREs		(23.5)		—
JHG's net interest in consolidated VREs	$	158.0	$	32.4

The increase in consolidated VREs is primarily due to approximately $163 million of seed capital investments into certain exchange-traded funds (“ETF”) products in September 2021.

Our total exposure to consolidated VREs represents the value of our economic ownership interest in these seeded investment products.

Unconsolidated Voting Rights Entities

The following table presents the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VREs (in millions):

	September 30,		December 31,
	2021		2020
Unconsolidated VREs	$	56.0	$	63.6

Our total exposure to unconsolidated VREs represents the value of our economic ownership interest in the investment securities.

XML

Investment Securities

9 Months Ended

Sep. 30, 2021

Investment Securities.

Investment Securities

Note 3 — Investment Securities

Our investment securities as of September 30, 2021, and December 31, 2020, are summarized as follows (in millions):

	September 30,		December 31,
	2021		2020
Seeded investment products:
Consolidated VIEs	$	245.3	$	214.6
Consolidated VREs		179.3		29.3
Unconsolidated VIEs and VREs		155.8		73.2
Separate accounts		54.2		63.5
Pooled investment funds		0.1		0.1
Total seeded investment products		634.7		380.7
Investments related to deferred compensation plans		50.3		96.5
Other investments		5.5		5.5
Total investment securities	$	690.5	$	482.7

Trading Securities

Net unrealized gains on investment securities held as of the three and nine months ended September 30, 2021 and 2020, are summarized as follows (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Unrealized gains on investment securities held at period end	$	4.6	$	25.5	$	8.0	$	34.1

Investment Gains, Net

Investment gains, net on our Condensed Consolidated Statements of Comprehensive Income (Loss) included the following for the three and nine months ended September 30, 2021 and 2020 (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Seeded investment products and hedges, net	$	1.4	$	5.2	$	4.4	$	11.2
Third-party ownership interests in seeded investment products		3.0		18.1		(1.1)		8.7
Long Tail Alpha equity method investment		0.2		0.4		2.1		6.1
Deferred equity plan		0.2		1.4		2.3		(1.2)
Other		(0.1)		0.4		0.4		0.5
Investment gains, net	$	4.7	$	25.5	$	8.1	$	25.3

Cash Flows

Cash flows related to investment securities for the nine months ended September 30, 2021 and 2020, are summarized as follows (in millions):

	Nine months ended September 30,
	2021				2020
			Sales,				Sales,
	Purchases		settlements		Purchases		settlements
	and		and		and		and
	settlements		maturities		settlements		maturities
Investment securities by consolidated seeded investment products	$	(66.9)	$	8.9	$	(69.3)	$	4.5
Investment securities		(302.2)		105.7		(109.5)		158.3

XML

Derivative Instruments

9 Months Ended

Sep. 30, 2021

Derivative Instruments

Derivative Instruments

Note 4 — Derivative Instruments

Derivative Instruments Used to Hedge Seeded Investment Products

We maintain an economic hedge program that uses derivative instruments to mitigate against market volatility of certain seeded investments by using index and commodity futures (“futures”), index swaps, total return swaps (“TRSs”) and credit default swaps. Foreign currency exposures associated with our seeded investment products are also hedged by using foreign currency forward contracts and swaps.

We were party to the following derivative instruments as of September 30, 2021, and December 31, 2020 (in millions):

	Notional value
	September 30, 2021		December 31, 2020
Futures	$	373.6	$	164.5
Credit default swaps		164.4		166.2
Total return swaps		59.6		35.6
Foreign currency forward contracts and swaps		390.3		205.0

The derivative instruments are not designated as hedges for accounting purposes. Changes in fair value of the derivatives are recognized in investment gains, net in our Condensed Consolidated Statements of Comprehensive Income (Loss).

Derivative assets and liabilities are generally recognized on a gross basis and included in other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. The derivative assets and liabilities as of September 30, 2021, and December 31, 2020, are summarized as follows (in millions):

	Fair value
	September 30, 2021		December 31, 2020
Derivative assets	$	12.2	$	9.1
Derivative liabilities		8.6		10.8

In addition to using derivative instruments to mitigate against market volatility of certain seeded investments, we also engage in short sales of securities to hedge seed investments. As of September 30, 2021, and December 31, 2020, the fair value of securities sold but not yet purchased was $2.9 million and $7.9 million, respectively. The cash received from the short sale and the obligation to repurchase the shares are classified in other current assets and accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets, respectively. Fair value adjustments are recognized in investment gains, net on our Condensed Consolidated Statements of Comprehensive Income (Loss).

Derivative Instruments in Consolidated Seeded Investment Products

Certain of our consolidated seeded investment products utilize derivative instruments to contribute to the achievement of defined investment objectives. These derivative instruments are classified within other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. Gains and losses on these derivative instruments are classified within investment gains, net in our Condensed Consolidated Statements of Comprehensive Income (Loss).

Our consolidated seeded investment products were party to the following derivative instruments as of September 30, 2021, and December 31, 2020 (in millions):

	Notional value
	September 30, 2021		December 31, 2020
Futures	$	96.4	$	57.0
Credit default swaps		5.5		1.5
Interest rate swaps		3.8		75.0
Options		0.3		0.5
Foreign currency forward contracts and swaps		83.3		56.1

Derivative Instruments — Used in Foreign Currency Hedging Program

In January 2021, we implemented a balance sheet foreign currency hedging program (the “Program”) to take reasonable measures to minimize the effects of foreign currency remeasurement of monetary balance sheet accounts. The Program is not designed to eliminate all impacts of foreign currency risk; rather it is designed to reduce income statement volatility. The Program utilizes foreign currency forward contracts and swaps to achieve its objectives, and it is considered an economic hedge for accounting purposes.

The notional value of the foreign currency forward contracts and swaps was $104.7 million at September 30, 2021. The derivative assets and liabilities are generally recognized on a gross basis and included in other current assets or accounts payable and accrued liabilities on our Condensed Consolidated Balance Sheets. The derivative assets and liabilities as of September 30, 2021, are summarized as follows (in millions):

	Fair value
	September 30, 2021
Derivative liabilities	$	1.9

Changes in fair value of the derivatives are recognized in other non-operating income (expenses), net on our Condensed Consolidated Statements of Comprehensive Income (Loss), and we recognized a loss of $0.8 million and a gain of $0.5 million during the three and nine months ended September 30, 2021, respectively. Foreign currency remeasurement is also recognized in other non-operating income (expenses), net on our Condensed Consolidated Statement of Comprehensive Income (Loss).

XML

Fair Value Measurements

9 Months Ended

Sep. 30, 2021

Fair Value Measurements

Fair Value Measurements

Note 5 — Fair Value Measurements

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of September 30, 2021 (in millions):

	Fair value measurements using:
	Quoted prices in
	active markets for
	identical assets		Significant other		Significant
	and liabilities		observable inputs		unobservable inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Cash equivalents	$	384.5	$	—	$	—	$	384.5
Investment securities:
Consolidated VIEs		194.7		43.8		6.8		245.3
Other investment securities		418.6		26.6		—		445.2
Total investment securities		613.3		70.4		6.8		690.5
Seed hedge derivatives		—		12.2		—		12.2
Derivatives in consolidated seeded investment products		—		0.1		—		0.1
Volantis contingent consideration		—		—		2.0		2.0
Geneva contingent consideration		—		—		12.0		12.0
Total assets	$	997.8	$	82.7	$	20.8	$	1,101.3
Liabilities:
Derivatives in consolidated seeded investment products	$	—	$	0.6	$	—	$	0.6
Derivatives used in foreign currency hedging program		—		1.9		—		1.9
Securities sold, not yet purchased		2.9		—		—		2.9
Seed hedge derivatives		—		8.6		—		8.6
Long-term debt(1)		—		336.8		—		336.8
Deferred bonuses		—		—		42.8		42.8
Total liabilities	$	2.9	$	347.9	$	42.8	$	393.6

(1) Carried at amortized cost and disclosed at fair value.

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of December 31, 2020 (in millions):

	Fair value measurements using:
	Quoted prices in
	active markets for
	identical assets		Significant other		Significant
	and liabilities		observable inputs		unobservable inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Cash equivalents	$	525.0	$	—	$	—	$	525.0
Investment securities:
Consolidated VIEs		125.7		77.7		11.2		214.6
Other investment securities		230.9		37.2		—		268.1
Total investment securities		356.6		114.9		11.2		482.7
Seed hedge derivatives		—		9.1		—		9.1
Derivatives in consolidated seeded investment products		—		0.9		—		0.9
Volantis contingent consideration		—		—		2.8		2.8
Geneva contingent consideration		—		—		17.4		17.4
Total assets	$	881.6	$	124.9	$	31.4	$	1,037.9
Liabilities:
Derivatives in consolidated seeded investment products	$	—	$	0.2	$	—	$	0.2
Securities sold, not yet purchased		7.9		—		—		7.9
Seed hedge derivatives		—		10.8		—		10.8
Long-term debt(1)		—		348.4		—		348.4
Deferred bonuses		—		—		65.2		65.2
Total liabilities	$	7.9	$	359.4	$	65.2	$	432.5

(1) Carried at amortized cost and disclosed at fair value.

Level 1 Fair Value Measurements

Our Level 1 fair value measurements consist mostly of investments held by seeded investment products, investments in advised mutual funds, cash equivalents and investments related to deferred compensation plans with quoted market prices in active markets. The fair value level of consolidated investments held by seeded investment products is determined by the underlying securities of the product. The fair value level of unconsolidated investments held in seeded investment products is determined by the net asset value (“NAV”), which is considered a quoted price in an active market.

Level 2 Fair Value Measurements

Our Level 2 fair value measurements consist mostly of consolidated seeded investment products, derivative instruments and our long-term debt. The fair value of consolidated seeded investment products is determined by the underlying securities of the product. The fair value of our long-term debt is determined using broker quotes and recent trading activity, which are considered Level 2 inputs.

Level 3 Fair Value Measurements

Investment Securities

As of September 30, 2021, and December 31, 2020, certain securities within consolidated VIEs were valued using significant unobservable inputs, resulting in Level 3 classification. In addition, we have an investment in a private equity vehicle where the significant valuation inputs are unobservable.

Geneva Contingent Consideration

On December 3, 2019, Henderson Global Investors (North America), Inc. (“HGINA”), a subsidiary of the Company, entered into an agreement to sell its 100% ownership interest in Geneva Capital Management LLC (“Geneva”) to GCM Purchaser, LLC. The sale closed on March 17, 2020. Consideration included aggregate cash consideration of $38.4 million and contingent consideration (the “Earnout”) based on future revenue. Payments under the Earnout are to be made quarterly over a five-year term, with minimum aggregate payments of $20.5 million and maximum aggregate payments of $35.0 million. During the three and nine months ended September 30, 2021, we received a $1.9 million and $5.4 million contingent consideration payment, respectively.

Volantis Contingent Consideration

On April 1, 2017, we completed the sale of the Volantis UK Small Cap (“Volantis”) alternative team assets. Consideration for the sale was a 10% share of the management and performance fees generated by Volantis (excluding one particular fund) for a period of three years following the sale. In addition, consideration for the sale included 50% of the first £12 million of performance fees generated by the excluded fund referenced above. As of September 30, 2021, the fund has not reached the £12 million performance fee threshold. As a result, this fee sharing arrangement will remain in effect until the performance threshold is reached.

As of September 30, 2021, and December 31, 2020, the fair value of the Volantis contingent consideration was $2.0 million and $2.8 million, respectively.

Deferred Bonuses

Deferred bonuses represent liabilities to employees over the vesting period that will be settled by investments in our products. The significant unobservable inputs used to value the liabilities are investment designations and vesting periods.

Changes in Fair Value

Changes in fair value of our Level 3 assets for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Beginning of period fair value	$	26.5	$	29.2	$	31.4	$	12.8
Contingent consideration from sale of Geneva		—		(1.4)		—		18.9
Settlements		(5.2)		—		(9.2)		(2.2)
Fair value adjustments		(0.2)		(1.6)		(2.7)		(3.3)
Purchases of securities		—		0.2		2.7		0.5
Sales of securities		—		—		(1.1)		—
Foreign currency translation		(0.3)		0.2		(0.3)		(0.1)
End of period fair value	$	20.8	$	26.6	$	20.8	$	26.6

Changes in fair value of our individual Level 3 liabilities for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021		2020
	Deferred		Deferred
	bonuses		bonuses
Beginning of period fair value	$	35.6	$	42.9
Fair value adjustments		1.1		0.8
Vesting of deferred bonuses		(0.9)		(1.4)
Amortization of deferred bonuses		7.9		8.1
Foreign currency translation		(0.9)		1.8
End of period fair value	$	42.8	$	52.2

	Nine months ended September 30,
	2021		2020
	Deferred		Contingent		Deferred
	bonuses		consideration		bonuses
Beginning of period fair value	$	65.2	$	21.2	$	76.6
Fair value adjustments		5.4		(7.1)		(0.3)
Vesting of deferred bonuses		(51.6)		—		(48.1)
Amortization of deferred bonuses		24.0		—		26.7
Unrealized gains (losses)		—		0.3		—
Distributions		—		(13.8)		—
Foreign currency translation		(0.2)		(0.6)		(2.7)
End of period fair value	$	42.8	$	—	$	52.2

Nonrecurring Fair Value Measurements

Nonrecurring Level 3 fair value measurements include goodwill and intangible assets. We measure the fair value of goodwill and intangible assets on initial recognition using discounted cash flow (“DCF”) analysis that requires assumptions regarding projected future earnings and discount rates. Because of the significance of the unobservable inputs in the fair value measurements of these assets, such measurements are classified as Level 3.

XML

Goodwill and Intangible Assets

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets

Goodwill and Intangible Assets

Note 6 — Goodwill and Intangible Assets

The following tables present movements in our intangible assets and goodwill during the nine months ended September 30, 2021 and 2020 (in millions):

	December 31,								Foreign  currency		September 30,
	2020		Amortization		Disposal		Impairment		translation		2021
Indefinite-lived intangible assets:
Investment management agreements	$	2,242.9	$	—	$	—	$	(40.8)	$	(13.7)	$	2,188.4
Trademarks		373.2		—		—		(3.6)		(0.1)		369.5
Definite-lived intangible assets:
Client relationships		170.9		—		—		—		(2.9)		168.0
Accumulated amortization		(100.7)		(5.8)		—		—		1.5		(105.0)
Net intangible assets	$	2,686.3	$	(5.8)	$	—	$	(44.4)	$	(15.2)	$	2,620.9
Goodwill	$	1,383.9	$	—	$	—	$	—	$	(13.1)	$	1,370.8

	December 31,								Foreign  currency		September 30,
	2019		Amortization		Disposal		Impairment		translation		2020
Indefinite-lived intangible assets:
Investment management agreements	$	2,490.3	$	—	$	—	$	(263.5)	$	(12.7)	$	2,214.1
Trademarks		380.8		—		—		(7.7)		(0.1)		373.0
Definite-lived intangible assets:
Client relationships		364.7		—		(79.3)		(119.0)		(0.3)		166.1
Accumulated amortization		(147.2)		(10.5)		61.4		—		0.6		(95.7)
Net intangible assets	$	3,088.6	$	(10.5)	$	(17.9)	$	(390.2)	$	(12.5)	$	2,657.5
Goodwill	$	1,504.3	$	—	$	(23.5)	$	(123.5)	$	(15.4)	$	1,341.9

Interim Impairment Assessment

During the second quarter of 2021, we performed an interim impairment assessment on a certain indefinite-lived intangible asset due to a significant decrease in assets under management (“AUM”) and unfavorable changes in the forecast on these specific assets. A DCF model was used to determine the estimated fair value of the investment management agreements. Some of the inputs used in the DCF model required significant management judgment, including the discount rate, terminal growth rate, forecasted financial results and market returns. The results of the DCF model revealed a fair value of nil and we therefore impaired the entire $40.8 million balance of the intangible asset. The impairment charge is included in the table above and recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

Perkins Trademark

During the first quarter of 2021, as part of our ongoing strategic initiatives and looking globally at delivering excellent service to our clients and positioning our business for success, we completed a review of Perkins Investment Management (“Perkins”). To right-size our product portfolio and better align with the changing needs of clients, certain strategies were closed and the funds were liquidated during the second quarter of 2021. The majority of the Perkins value equity strategies were unaffected by this reorganization and they have continued under the Janus Henderson brand. The Perkins brand was discontinued and the marketing efforts for value equity strategies were incorporated under the Janus Henderson brand. During the first quarter 2021, we impaired the entire balance of the intangible asset associated with the Perkins trademark. The impairment charge of $3.6 million is included in the table above and recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

Sale of Geneva

On December 3, 2019, HGINA, a subsidiary of JHG, entered into an agreement to sell its 100% ownership interest in Geneva to GCM Purchaser, LLC. The sale closed on March 17, 2020. The transaction included $17.9 million of net intangible assets and goodwill of $23.5 million, as disclosed in the disposal column above.

2020 Goodwill and Intangible Asset Impairments

In March 2020, the World Health Organization declared COVID-19 a pandemic, and global financial markets declined. This drove a sudden and severe decline in our AUM, which was a triggering event for performing an interim impairment assessment of our goodwill and intangible assets. Our interim impairment assessment revealed the carrying value of certain investment management agreements, trademarks, client relationships and goodwill exceeded their estimated fair value, and we recognized impairments of $263.5 million, $7.7 million, $92.6 million and $123.5 million, respectively, during the three months ended March 31, 2020. The results of the March 2020 interim assessment are included in the table above. The impairment charges were recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

VelocityShares Exchange-Traded Notes

In June 2020, a third-party issuer announced its intent to delist and suspend further issuances of the majority of VelocityShares exchange-traded notes (“ETNs”). The announcement was considered a triggering event for performing an interim impairment assessment of the definite-lived intangible asset. We qualitatively assessed the asset and considered how the announcement is expected to negatively impact ETN asset levels in the short and long term. While there will likely continue to be short-term revenue associated with the ETNs after they are delisted, the asset value is expected to decrease until the products become fully liquidated. As such, we impaired the entire intangible asset associated with the VelocityShares ETNs in June 2020. The impairment charge of $26.4 million is included in the table above and recorded in goodwill and intangible asset impairment charges on the Condensed Consolidated Statements of Comprehensive Income (Loss).

Future Amortization

Expected future amortization expense related to client relationships is summarized below (in millions):

Future amortization	Amount
2021 (remainder of year)	$	1.9
2022		7.6
2023		7.3
2024		5.9
2025		5.9
Thereafter		34.4
Total	$	63.0

XML

Debt

9 Months Ended

Sep. 30, 2021

Debt

Debt

Note 7 — Debt

Our debt as of September 30, 2021, and December 31, 2020, consisted of the following (in millions):

	September 30, 2021				December 31, 2020
	Carrying		Fair		Carrying		Fair
	value		value		value		value
4.875% Senior Notes due 2025	$	311.1	$	336.8	$	313.3	$	348.4

4.875% Senior Notes Due 2025

The 4.875% Senior Notes due 2025 (“2025 Senior Notes”) have a principal value of $300.0 million, pay interest at 4.875% semiannually on February 1 and August 1 of each year, and mature on August 1, 2025. The 2025 Senior Notes include unamortized debt premium, net at September 30, 2021, of $11.1 million, which will be amortized over the remaining life of the notes. The unamortized debt premium is recorded as a liability within long-term debt on our Condensed Consolidated Balance Sheets. JHG fully and unconditionally guarantees the obligations of Janus Capital Group Inc. (“JCG”) in relation to the 2025 Senior Notes.

Credit Facility

At September 30, 2021, we had a $200 million, unsecured, revolving credit facility (“Credit Facility”). JHG and its subsidiaries may use the Credit Facility for general corporate purposes. The rate of interest for each interest period is the aggregate of the applicable margin, which is based on our long-term credit rating and the London Interbank Offered Rate (“LIBOR”); the Euro Interbank Offered Rate (“EURIBOR”) in relation to any loan in euro (“EUR”); or in relation to any loan in Australian dollar (“AUD”), the benchmark rate for that currency. As LIBOR is scheduled to be phased out at the end of 2021, we are working with our banking syndicate to find a suitable replacement. We are required to pay a quarterly commitment fee on any unused portion of the Credit Facility, which is also based on our long-term credit rating. Under the Credit Facility, our financing leverage ratio cannot exceed 3.00x EBITDA. At September 30, 2021, we were in compliance with all covenants contained in, and there were no outstanding borrowings under, the Credit Facility. The maturity date of the Credit Facility is February 16, 2024.

XML

Income Taxes

9 Months Ended

Sep. 30, 2021

Income Taxes

Income Taxes

Note 8 — Income Taxes

Our effective tax rates for the three and nine months ended September 30, 2021 and 2020, were as follows:

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Effective tax rate	21.0	%	22.9	%	26.5	%	(15.3)	%

The change in the three months ended September 30, 2020 and the three months ended September 30, 2021 is primarily related to the enactment of Finance Act 2020, where the United Kingdom (“UK”) government announced the UK tax rate would remain at 19% and not reduce to 17% as scheduled, resulting in a deferred tax expense in the three months ended September 30, 2020.

The effective tax rate for the nine months ended September 30, 2021, compared to the nine months ended September 30, 2020, was impacted by the enactment of Finance Act 2021 during the second quarter of 2021, which increased the UK corporation tax rate from 19% to 25% beginning in April 2023. As a result, the UK deferred tax assets and liabilities expected to be settled after 2023 were revalued from 19% to 25%, creating a non-cash deferred tax expense of $31.0 million. The effective tax rate for the nine months ended September 30, 2020, was also impacted by the enactment of Finance Act 2020, as discussed above. In addition, there were significant impairments of intangible assets and goodwill in the first quarter of 2020, which contributed to a pre-tax book loss for the nine months ended September 30, 2020. The majority of the impairment charges were related to temporary differences, which adjusted deferred income taxes and did not have a direct impact on the effective tax rate.

As of September 30, 2021, and December 31, 2020, we had $14.9 million and $15.8 million of unrecognized tax benefits held for uncertain tax positions, respectively. We estimate that the existing liability for uncertain tax positions could decrease by up to $0.6 million within the next 12 months, without giving effect to changes in foreign currency translation.

XML

Noncontrolling Interests

9 Months Ended

Sep. 30, 2021

Noncontrolling Interests

Noncontrolling Interests

Note 9 — Noncontrolling Interests

Redeemable Noncontrolling Interests

Redeemable noncontrolling interests as of September 30, 2021, and December 31, 2020, consisted of the following (in millions):

	September 30,		December 31,
	2021		2020
Consolidated seeded investment products	$	130.2	$	70.6
Intech:
Employee appreciation rights		12.7		12.3
Founding member ownership interests		2.2		2.9
Total redeemable noncontrolling interests	$	145.1	$	85.8

Consolidated Seeded Investment Products

Noncontrolling interests in consolidated seeded investment products are classified as redeemable noncontrolling interests when there is an obligation to repurchase units at the investor’s request.

Redeemable noncontrolling interests in consolidated seeded investment products may fluctuate from period to period and are impacted by changes in our relative ownership, changes in the amount of third-party investment in seeded products and volatility in the market value of the underlying securities included in the portfolios of seeded products. Redemptions of investments by third parties in any particular seeded product are redeemed from the net assets of such seeded product and cannot be redeemed from the assets of our other seeded products or from our other assets.

The following table presents the movement in redeemable noncontrolling interests in consolidated seeded investment products for the three and nine months ended September 30, 2021 and 2020 (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Opening balance	$	109.2	$	453.7	$	70.6	$	662.8
Changes in market value		3.0		18.8		0.6		10.9
Changes in ownership		18.4		(413.1)		58.5		(610.0)
Foreign currency translation		(0.4)		11.4		0.5		7.1
Closing balance	$	130.2	$	70.8	$	130.2	$	70.8

Intech

Intech Investment Management LLC (“Intech”) ownership interests held by a founding member had an estimated fair value of $2.2 million as of September 30, 2021, representing an approximate 1.1% ownership of Intech. This founding member is entitled to retain his remaining Intech interests for the remainder of his life and has the option to require us to purchase his ownership interests in Intech at fair value.

Intech employee appreciation rights are amortized using a graded vesting method over the respective vesting period. The appreciation rights are exercisable upon termination of employment from Intech to the extent vested. Upon exercise, the appreciation rights are settled in Intech equity.

Nonredeemable Noncontrolling Interests

Nonredeemable noncontrolling interests as of September 30, 2021, and December 31, 2020, were as follows (in millions):

	September 30,		December 31,
	2021		2020
Nonredeemable noncontrolling interests in:
Seed capital investments	$	2.9	$	4.6
Intech		12.7		12.8
Total nonredeemable noncontrolling interests	$	15.6	$	17.4

XML

Long-Term Incentive Compensation

9 Months Ended

Sep. 30, 2021

Long-Term Incentive Compensation

Long-Term Incentive Compensation

Note 10 — Long-Term Incentive and Employee Compensation

The following table presents restricted stock and mutual fund awards granted during the three and nine months ended September 30, 2021 (in millions):

	Three months ended		Nine months ended
	September 30,		September 30,
	2021		2021
Restricted stock	$	1.0	$	69.5
Mutual fund awards		0.1		75.5
Total	$	1.1	$	145.0

Restricted stock and mutual fund awards generally vest and will be recognized using a graded vesting method over a three- or four-year period.

XML

Retirement Benefit Plans

9 Months Ended

Sep. 30, 2021

Retirement Benefit Plans

Retirement Benefit Plans

Note 11 — Retirement Benefit Plans

We operate defined contribution retirement benefit plans and defined benefit pension plans.

Our primary defined benefit pension plan is the defined benefit section of the Janus Henderson Group UK Pension Scheme (“JHGPS”).

Net Periodic Benefit Credit

The components of net periodic benefit credit in respect of defined benefit plans for the three and nine months ended September 30, 2021 and 2020, include the following (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Service cost	$	(0.2)	$	(0.2)	$	(0.7)	$	(0.6)
Interest cost		(2.8)		(4.3)		(8.4)		(12.9)
Amortization of prior service cost		(0.1)		(0.1)		(0.3)		(0.3)
Expected return on plan assets		3.3		4.7		10.0		13.9
Net periodic benefit credit	$	0.2	$	0.1	$	0.6	$	0.1
Total cost

XML

Accumulated Other Comprehensive Loss

9 Months Ended

Sep. 30, 2021

Accumulated Other Comprehensive Loss.

Accumulated Other Comprehensive Loss

Note 12 — Accumulated Other Comprehensive Loss

Changes in accumulated other comprehensive loss, net of tax for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021						2020
	Foreign		Retirement benefit				Foreign		Retirement benefit
	currency		asset, net		Total		currency		asset, net		Total
Beginning balance	$	(308.1)	$	(10.1)	$	(318.2)	$	(521.0)	$	19.3	$	(501.7)
Other comprehensive income (loss)		(59.6)		—		(59.6)		97.6		(0.2)		97.4
Amounts reclassified from accumulated other comprehensive loss		—		0.1		0.1		(0.2)		0.3		0.1
Total other comprehensive income (loss)		(59.6)		0.1		(59.5)		97.4		0.1		97.5
Less: other comprehensive loss (income) attributable to noncontrolling interests		0.8		—		0.8		(11.0)		—		(11.0)
Ending balance	$	(366.9)	$	(10.0)	$	(376.9)	$	(434.6)	$	19.4	$	(415.2)

	Nine months ended September 30,
	2021						2020
	Foreign		Retirement benefit				Foreign		Retirement benefit
	currency		asset, net		Total		currency		asset, net		Total
Beginning balance	$	(313.6)	$	(10.4)	$	(324.0)	$	(386.2)	$	19.1	$	(367.1)
Other comprehensive income (loss)		(48.9)		0.1		(48.8)		(39.5)		—		(39.5)
Amounts reclassified from accumulated other comprehensive loss		(4.2)		0.3		(3.9)		(1.6)		0.3		(1.3)
Total other comprehensive income (loss)		(53.1)		0.4		(52.7)		(41.1)		0.3		(40.8)
Less: other comprehensive loss (income) attributable to noncontrolling interests		(0.2)		—		(0.2)		(7.3)		—		(7.3)
Ending balance	$	(366.9)	$	(10.0)	$	(376.9)	$	(434.6)	$	19.4	$	(415.2)

The components of other comprehensive income (loss), net of tax for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021						2020
	Pre-tax		Tax		Net		Pre-tax		Tax		Net
	amount		impact		amount		amount		impact		amount
Foreign currency translation adjustments	$	(60.2)	$	0.6	$	(59.6)	$	98.2	$	(0.6)	$	97.6
Retirement benefit asset, net		—		—		—		(0.2)		—		(0.2)
Reclassifications to net income		0.1		—		0.1		0.1		—		0.1
Total other comprehensive income (loss)	$	(60.1)	$	0.6	$	(59.5)	$	98.1	$	(0.6)	$	97.5

	Nine months ended September 30,
	2021						2020
	Pre-tax		Tax		Net		Pre-tax		Tax			Net
	amount		impact		Amount		amount		impact			Amount
Foreign currency translation adjustments	$	(50.5)	$	1.6	$	(48.9)	$	(41.0)	$	1.5	$	(39.5)
Retirement benefit asset, net		—		0.1		0.1		—		—		—
Reclassifications to net income		(3.9)		—		(3.9)		(1.3)		—		(1.3)
Total other comprehensive income (loss)	$	(54.4)	$	1.7	$	(52.7)	$	(42.3)	$	1.5	$	(40.8)

XML

Earnings and Dividends Per Share

9 Months Ended

Sep. 30, 2021

Earnings and Dividends Per Share

Earnings (Loss) and Dividends Per Share

Note 13 — Earnings (Loss) and Dividends Per Share

Earnings (Loss) Per Share

The following is a summary of the earnings (loss) per share calculation for the three and nine months ended September 30, 2021 and 2020 (in millions, except per share data):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Net income (loss) attributable to JHG	$	196.8	$	118.9	$	489.6	$	(25.2)
Allocation of earnings to participating stock-based awards		(5.4)		(3.5)		(14.1)		—
Net income (loss) attributable to JHG common shareholders	$	191.4	$	115.4	$	475.5	$	(25.2)
Weighted-average common shares outstanding — basic		167.1		178.4		168.7		180.4
Dilutive effect of nonparticipating stock-based awards		0.7		0.4		0.7		—
Weighted-average common shares outstanding — diluted		167.8		178.8		169.4		180.4
Earnings (loss) per share:
Basic (two class)	$	1.15	$	0.65	$	2.82	$	(0.14)
Diluted (two class)	$	1.14	$	0.65	$	2.81	$	(0.14)

The following instruments are anti-dilutive and have not been included in the weighted-average diluted shares outstanding calculation (in millions):

	Three months ended		Nine months ended
	September 30,		September 30,
	2021	2020	2021	2020
Unvested nonparticipating stock awards	0.3	0.8	0.5	1.5

Dividends Per Share

The payment of cash dividends is within the discretion of our Board of Directors and depends on many factors, including, but not limited to, our results of operations, financial condition, capital requirements, legal requirements and general business conditions.

The following is a summary of cash dividends paid during the nine months ended September 30, 2021:

Dividend		Date	Dividends paid		Date
per share		declared	(in US$ millions)		paid
$	0.36	February 3, 2021	$	61.7	March 3, 2021
$	0.38	April 28, 2021	$	65.0	May 27, 2021
$	0.38	July 28, 2021	$	64.8	August 25, 2021

On October 27, 2021, our Board of Directors declared a cash dividend of $0.38 per share. The quarterly dividend will be paid on November 24, 2021, to shareholders of record at the close of business on November 8, 2021.

XML

Commitments and Contingencies

9 Months Ended

Sep. 30, 2021

Commitments and Contingencies

Commitments and Contingencies

Note 14 — Commitments and Contingencies

Related Party Transactions

On February 4, 2021, Dai-ichi Life Holdings, Inc. (“Dai-ichi Life”) announced its intention to sell all 30,668,922 shares of JHG common stock it owned by means of a registered secondary public offering. On February 9, 2021, Dai-ichi Life completed the secondary offering, and as part of the offering, we repurchased 8,048,360 shares of common stock from Dai-ichi Life for approximately $230.0 million through Goldman Sachs & Co. LLC (“as underwriter”) at the price at which the shares of common stock were sold to the public in the secondary offering, less the underwriting discount. As a result of the completion of the secondary offering, Dai-ichi Life no longer owns any shares of JHG common stock. We did not receive any proceeds from Dai-ichi Life’s sale of common stock in the secondary offering.

Litigation and Other Regulatory Matters

We are periodically involved in various legal proceedings and other regulatory matters. Although there can be no assurances, based on information currently available, we believe that it is probable that the ultimate outcome of matters that are pending or threatened will not have a material effect on our consolidated financial statements.

XML

Basis of Presentation and Significant Accounting Policies (Policies)

9 Months Ended

Sep. 30, 2021

Basis of Presentation and Significant Accounting Policies

Basis of Presentation

Basis of Presentation

In the opinion of management of Janus Henderson Group plc (“JHG,” “the Company,” “we,” “us,” “our” and similar terms), the accompanying unaudited condensed consolidated financial statements contain all normal recurring adjustments necessary to fairly state our financial position, results of operations and cash flows in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Such financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in annual financial statements prepared in accordance with GAAP are not required for interim reporting purposes and have been condensed or omitted pursuant to such rules and regulations. These financial statements should be read in conjunction with the annual consolidated financial statements and notes presented in our Annual Report on Form 10-K for the year ended December 31, 2020. Events subsequent to the balance sheet date have been evaluated for inclusion in the accompanying financial statements through the issuance date.

Recent Accounting Pronouncements Adopted

Recent Accounting Pronouncements Adopted

Income Taxes

In December 2019, the Financial Accounting Standards Board (“FASB”) issued accounting standards update (“ASU”) 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, which is part of the FASB’s initiative to reduce complexity in accounting standards. The ASU eliminates certain exceptions to the general principles of ASC 740, Income Taxes, and simplifies income tax accounting in several areas. We adopted the ASU, which was effective as of January 1, 2021. The adoption of this ASU did not have a material impact on our results of operations or financial position.

XML

Consolidation (Tables)

9 Months Ended

Sep. 30, 2021

Consolidation

Schedule of unconsolidated variable interest entities (VIEs)

The following table presents the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VIEs (in millions):

	September 30,		December 31,
	2021		2020
Unconsolidated VIEs	$	99.8	$	9.6

Schedule of consolidated voting right entities (VREs)

The following table presents the balances related to consolidated voting rights entities (“VREs”) that were recorded on our Condensed Consolidated Balance Sheets, including our net interest in these products (in millions):

	September 30,		December 31,
	2021		2020
Investment securities	$	179.3	$	29.3
Cash and cash equivalents		2.3		2.8
Other current assets		0.8		0.4
Accounts payable and accrued liabilities		(0.9)		(0.1)
Total	$	181.5	$	32.4
Redeemable noncontrolling interests in consolidated VREs		(23.5)		—
JHG's net interest in consolidated VREs	$	158.0	$	32.4

Schedule of unconsolidated voting right entities (VREs)

The following table presents the carrying value of investment securities included on our Condensed Consolidated Balance Sheets pertaining to unconsolidated VREs (in millions):

	September 30,		December 31,
	2021		2020
Unconsolidated VREs	$	56.0	$	63.6

XML

Investment Securities (Tables)

9 Months Ended

Sep. 30, 2021

Investment Securities.

Summary of investment securities

Our investment securities as of September 30, 2021, and December 31, 2020, are summarized as follows (in millions):

	September 30,		December 31,
	2021		2020
Seeded investment products:
Consolidated VIEs	$	245.3	$	214.6
Consolidated VREs		179.3		29.3
Unconsolidated VIEs and VREs		155.8		73.2
Separate accounts		54.2		63.5
Pooled investment funds		0.1		0.1
Total seeded investment products		634.7		380.7
Investments related to deferred compensation plans		50.3		96.5
Other investments		5.5		5.5
Total investment securities	$	690.5	$	482.7

Schedule of net unrealized gains on trading securities

Net unrealized gains on investment securities held as of the three and nine months ended September 30, 2021 and 2020, are summarized as follows (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Unrealized gains on investment securities held at period end	$	4.6	$	25.5	$	8.0	$	34.1

Schedule of investment gains (losses), net in Consolidated Statements of Comprehensive Income

Investment gains, net on our Condensed Consolidated Statements of Comprehensive Income (Loss) included the following for the three and nine months ended September 30, 2021 and 2020 (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Seeded investment products and hedges, net	$	1.4	$	5.2	$	4.4	$	11.2
Third-party ownership interests in seeded investment products		3.0		18.1		(1.1)		8.7
Long Tail Alpha equity method investment		0.2		0.4		2.1		6.1
Deferred equity plan		0.2		1.4		2.3		(1.2)
Other		(0.1)		0.4		0.4		0.5
Investment gains, net	$	4.7	$	25.5	$	8.1	$	25.3

Cash flows related to investment securities

Cash flows related to investment securities for the nine months ended September 30, 2021 and 2020, are summarized as follows (in millions):

	Nine months ended September 30,
	2021				2020
			Sales,				Sales,
	Purchases		settlements		Purchases		settlements
	and		and		and		and
	settlements		maturities		settlements		maturities
Investment securities by consolidated seeded investment products	$	(66.9)	$	8.9	$	(69.3)	$	4.5
Investment securities		(302.2)		105.7		(109.5)		158.3

XML

Derivative Instruments (Tables)

9 Months Ended

Sep. 30, 2021

Seeded investment products

Schedule of derivative instruments

Our consolidated seeded investment products were party to the following derivative instruments as of September 30, 2021, and December 31, 2020 (in millions):

	Notional value
	September 30, 2021		December 31, 2020
Futures	$	96.4	$	57.0
Credit default swaps		5.5		1.5
Interest rate swaps		3.8		75.0
Options		0.3		0.5
Foreign currency forward contracts and swaps		83.3		56.1

Forward foreign exchange contracts and swaps

Schedule of Derivative assets and liabilities

	Fair value
	September 30, 2021
Derivative liabilities	$	1.9

Not Designated as Hedging Instrument

Schedule of derivative instruments

We were party to the following derivative instruments as of September 30, 2021, and December 31, 2020 (in millions):

	Notional value
	September 30, 2021		December 31, 2020
Futures	$	373.6	$	164.5
Credit default swaps		164.4		166.2
Total return swaps		59.6		35.6
Foreign currency forward contracts and swaps		390.3		205.0

Not Designated as Hedging Instrument

Schedule of Derivative assets and liabilities

	Fair value
	September 30, 2021		December 31, 2020
Derivative assets	$	12.2	$	9.1
Derivative liabilities		8.6		10.8

XML

Fair Value Measurements (Tables)

9 Months Ended

Sep. 30, 2021

Fair Value Measurements

Schedule of assets and liabilities presented in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of September 30, 2021 (in millions):

	Fair value measurements using:
	Quoted prices in
	active markets for
	identical assets		Significant other		Significant
	and liabilities		observable inputs		unobservable inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Cash equivalents	$	384.5	$	—	$	—	$	384.5
Investment securities:
Consolidated VIEs		194.7		43.8		6.8		245.3
Other investment securities		418.6		26.6		—		445.2
Total investment securities		613.3		70.4		6.8		690.5
Seed hedge derivatives		—		12.2		—		12.2
Derivatives in consolidated seeded investment products		—		0.1		—		0.1
Volantis contingent consideration		—		—		2.0		2.0
Geneva contingent consideration		—		—		12.0		12.0
Total assets	$	997.8	$	82.7	$	20.8	$	1,101.3
Liabilities:
Derivatives in consolidated seeded investment products	$	—	$	0.6	$	—	$	0.6
Derivatives used in foreign currency hedging program		—		1.9		—		1.9
Securities sold, not yet purchased		2.9		—		—		2.9
Seed hedge derivatives		—		8.6		—		8.6
Long-term debt(1)		—		336.8		—		336.8
Deferred bonuses		—		—		42.8		42.8
Total liabilities	$	2.9	$	347.9	$	42.8	$	393.6

(1) Carried at amortized cost and disclosed at fair value.

The following table presents assets and liabilities reflected in the financial statements or disclosed in the notes to the financial statements at fair value on a recurring basis as of December 31, 2020 (in millions):

	Fair value measurements using:
	Quoted prices in
	active markets for
	identical assets		Significant other		Significant
	and liabilities		observable inputs		unobservable inputs
	(Level 1)		(Level 2)		(Level 3)		Total
Assets:
Cash equivalents	$	525.0	$	—	$	—	$	525.0
Investment securities:
Consolidated VIEs		125.7		77.7		11.2		214.6
Other investment securities		230.9		37.2		—		268.1
Total investment securities		356.6		114.9		11.2		482.7
Seed hedge derivatives		—		9.1		—		9.1
Derivatives in consolidated seeded investment products		—		0.9		—		0.9
Volantis contingent consideration		—		—		2.8		2.8
Geneva contingent consideration		—		—		17.4		17.4
Total assets	$	881.6	$	124.9	$	31.4	$	1,037.9
Liabilities:
Derivatives in consolidated seeded investment products	$	—	$	0.2	$	—	$	0.2
Securities sold, not yet purchased		7.9		—		—		7.9
Seed hedge derivatives		—		10.8		—		10.8
Long-term debt(1)		—		348.4		—		348.4
Deferred bonuses		—		—		65.2		65.2
Total liabilities	$	7.9	$	359.4	$	65.2	$	432.5

(1) Carried at amortized cost and disclosed at fair value.

Schedule of changes in fair value of the recurring Level 3 fair value measurements for collective items

Changes in fair value of our Level 3 assets for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Beginning of period fair value	$	26.5	$	29.2	$	31.4	$	12.8
Contingent consideration from sale of Geneva		—		(1.4)		—		18.9
Settlements		(5.2)		—		(9.2)		(2.2)
Fair value adjustments		(0.2)		(1.6)		(2.7)		(3.3)
Purchases of securities		—		0.2		2.7		0.5
Sales of securities		—		—		(1.1)		—
Foreign currency translation		(0.3)		0.2		(0.3)		(0.1)
End of period fair value	$	20.8	$	26.6	$	20.8	$	26.6

Schedule of changes in fair value of the recurring Level 3 fair value measurements for individual items

Changes in fair value of our individual Level 3 liabilities for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021		2020
	Deferred		Deferred
	bonuses		bonuses
Beginning of period fair value	$	35.6	$	42.9
Fair value adjustments		1.1		0.8
Vesting of deferred bonuses		(0.9)		(1.4)
Amortization of deferred bonuses		7.9		8.1
Foreign currency translation		(0.9)		1.8
End of period fair value	$	42.8	$	52.2

	Nine months ended September 30,
	2021		2020
	Deferred		Contingent		Deferred
	bonuses		consideration		bonuses
Beginning of period fair value	$	65.2	$	21.2	$	76.6
Fair value adjustments		5.4		(7.1)		(0.3)
Vesting of deferred bonuses		(51.6)		—		(48.1)
Amortization of deferred bonuses		24.0		—		26.7
Unrealized gains (losses)		—		0.3		—
Distributions		—		(13.8)		—
Foreign currency translation		(0.2)		(0.6)		(2.7)
End of period fair value	$	42.8	$	—	$	52.2

XML

Goodwill and Intangible Assets (Tables)

9 Months Ended

Sep. 30, 2021

Goodwill and Intangible Assets

Summary of goodwill and intangible assets

The following tables present movements in our intangible assets and goodwill during the nine months ended September 30, 2021 and 2020 (in millions):

	December 31,								Foreign  currency		September 30,
	2020		Amortization		Disposal		Impairment		translation		2021
Indefinite-lived intangible assets:
Investment management agreements	$	2,242.9	$	—	$	—	$	(40.8)	$	(13.7)	$	2,188.4
Trademarks		373.2		—		—		(3.6)		(0.1)		369.5
Definite-lived intangible assets:
Client relationships		170.9		—		—		—		(2.9)		168.0
Accumulated amortization		(100.7)		(5.8)		—		—		1.5		(105.0)
Net intangible assets	$	2,686.3	$	(5.8)	$	—	$	(44.4)	$	(15.2)	$	2,620.9
Goodwill	$	1,383.9	$	—	$	—	$	—	$	(13.1)	$	1,370.8

	December 31,								Foreign  currency		September 30,
	2019		Amortization		Disposal		Impairment		translation		2020
Indefinite-lived intangible assets:
Investment management agreements	$	2,490.3	$	—	$	—	$	(263.5)	$	(12.7)	$	2,214.1
Trademarks		380.8		—		—		(7.7)		(0.1)		373.0
Definite-lived intangible assets:
Client relationships		364.7		—		(79.3)		(119.0)		(0.3)		166.1
Accumulated amortization		(147.2)		(10.5)		61.4		—		0.6		(95.7)
Net intangible assets	$	3,088.6	$	(10.5)	$	(17.9)	$	(390.2)	$	(12.5)	$	2,657.5
Goodwill	$	1,504.3	$	—	$	(23.5)	$	(123.5)	$	(15.4)	$	1,341.9

Client relationships

Goodwill and Intangible Assets

Schedule of expected future amortization

Expected future amortization expense related to client relationships is summarized below (in millions):

Future amortization	Amount
2021 (remainder of year)	$	1.9
2022		7.6
2023		7.3
2024		5.9
2025		5.9
Thereafter		34.4
Total	$	63.0

XML

Debt (Tables)

9 Months Ended

Sep. 30, 2021

Debt

Components of debt

Our debt as of September 30, 2021, and December 31, 2020, consisted of the following (in millions):

	September 30, 2021				December 31, 2020
	Carrying		Fair		Carrying		Fair
	value		value		value		value
4.875% Senior Notes due 2025	$	311.1	$	336.8	$	313.3	$	348.4

XML

Income Taxes (Tables)

9 Months Ended

Sep. 30, 2021

Income Taxes

Schedule of effective income tax rates

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Effective tax rate	21.0	%	22.9	%	26.5	%	(15.3)	%

XML

Noncontrolling Interests (Tables)

9 Months Ended

Sep. 30, 2021

Noncontrolling Interests

Summary of redeemable noncontrolling interests

Redeemable noncontrolling interests as of September 30, 2021, and December 31, 2020, consisted of the following (in millions):

	September 30,		December 31,
	2021		2020
Consolidated seeded investment products	$	130.2	$	70.6
Intech:
Employee appreciation rights		12.7		12.3
Founding member ownership interests		2.2		2.9
Total redeemable noncontrolling interests	$	145.1	$	85.8

Schedule of movement in redeemable noncontrolling interests in consolidated seeded investment products

The following table presents the movement in redeemable noncontrolling interests in consolidated seeded investment products for the three and nine months ended September 30, 2021 and 2020 (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Opening balance	$	109.2	$	453.7	$	70.6	$	662.8
Changes in market value		3.0		18.8		0.6		10.9
Changes in ownership		18.4		(413.1)		58.5		(610.0)
Foreign currency translation		(0.4)		11.4		0.5		7.1
Closing balance	$	130.2	$	70.8	$	130.2	$	70.8

Summary of nonredeemable noncontrolling interests

Nonredeemable noncontrolling interests as of September 30, 2021, and December 31, 2020, were as follows (in millions):

	September 30,		December 31,
	2021		2020
Nonredeemable noncontrolling interests in:
Seed capital investments	$	2.9	$	4.6
Intech		12.7		12.8
Total nonredeemable noncontrolling interests	$	15.6	$	17.4

XML

Long-Term Incentive Compensation (Tables)

9 Months Ended

Sep. 30, 2021

Long-Term Incentive Compensation

Schedule of presents restricted stock and mutual fund awards granted

The following table presents restricted stock and mutual fund awards granted during the three and nine months ended September 30, 2021 (in millions):

	Three months ended		Nine months ended
	September 30,		September 30,
	2021		2021
Restricted stock	$	1.0	$	69.5
Mutual fund awards		0.1		75.5
Total	$	1.1	$	145.0

XML

Retirement Benefit Plans (Tables)

9 Months Ended

Sep. 30, 2021

Retirement Benefit Plans

Schedule of components of net periodic benefit credit

The components of net periodic benefit credit in respect of defined benefit plans for the three and nine months ended September 30, 2021 and 2020, include the following (in millions):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Service cost	$	(0.2)	$	(0.2)	$	(0.7)	$	(0.6)
Interest cost		(2.8)		(4.3)		(8.4)		(12.9)
Amortization of prior service cost		(0.1)		(0.1)		(0.3)		(0.3)
Expected return on plan assets		3.3		4.7		10.0		13.9
Net periodic benefit credit	$	0.2	$	0.1	$	0.6	$	0.1
Total cost

XML

Accumulated Other Comprehensive Loss (Tables)

9 Months Ended

Sep. 30, 2021

Accumulated Other Comprehensive Loss.

Schedule of the changes in accumulated other comprehensive loss, net of tax

Changes in accumulated other comprehensive loss, net of tax for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021						2020
	Foreign		Retirement benefit				Foreign		Retirement benefit
	currency		asset, net		Total		currency		asset, net		Total
Beginning balance	$	(308.1)	$	(10.1)	$	(318.2)	$	(521.0)	$	19.3	$	(501.7)
Other comprehensive income (loss)		(59.6)		—		(59.6)		97.6		(0.2)		97.4
Amounts reclassified from accumulated other comprehensive loss		—		0.1		0.1		(0.2)		0.3		0.1
Total other comprehensive income (loss)		(59.6)		0.1		(59.5)		97.4		0.1		97.5
Less: other comprehensive loss (income) attributable to noncontrolling interests		0.8		—		0.8		(11.0)		—		(11.0)
Ending balance	$	(366.9)	$	(10.0)	$	(376.9)	$	(434.6)	$	19.4	$	(415.2)

	Nine months ended September 30,
	2021						2020
	Foreign		Retirement benefit				Foreign		Retirement benefit
	currency		asset, net		Total		currency		asset, net		Total
Beginning balance	$	(313.6)	$	(10.4)	$	(324.0)	$	(386.2)	$	19.1	$	(367.1)
Other comprehensive income (loss)		(48.9)		0.1		(48.8)		(39.5)		—		(39.5)
Amounts reclassified from accumulated other comprehensive loss		(4.2)		0.3		(3.9)		(1.6)		0.3		(1.3)
Total other comprehensive income (loss)		(53.1)		0.4		(52.7)		(41.1)		0.3		(40.8)
Less: other comprehensive loss (income) attributable to noncontrolling interests		(0.2)		—		(0.2)		(7.3)		—		(7.3)
Ending balance	$	(366.9)	$	(10.0)	$	(376.9)	$	(434.6)	$	19.4	$	(415.2)

Components of other comprehensive income (loss), net of tax

The components of other comprehensive income (loss), net of tax for the three and nine months ended September 30, 2021 and 2020, were as follows (in millions):

	Three months ended September 30,
	2021						2020
	Pre-tax		Tax		Net		Pre-tax		Tax		Net
	amount		impact		amount		amount		impact		amount
Foreign currency translation adjustments	$	(60.2)	$	0.6	$	(59.6)	$	98.2	$	(0.6)	$	97.6
Retirement benefit asset, net		—		—		—		(0.2)		—		(0.2)
Reclassifications to net income		0.1		—		0.1		0.1		—		0.1
Total other comprehensive income (loss)	$	(60.1)	$	0.6	$	(59.5)	$	98.1	$	(0.6)	$	97.5

	Nine months ended September 30,
	2021						2020
	Pre-tax		Tax		Net		Pre-tax		Tax			Net
	amount		impact		Amount		amount		impact			Amount
Foreign currency translation adjustments	$	(50.5)	$	1.6	$	(48.9)	$	(41.0)	$	1.5	$	(39.5)
Retirement benefit asset, net		—		0.1		0.1		—		—		—
Reclassifications to net income		(3.9)		—		(3.9)		(1.3)		—		(1.3)
Total other comprehensive income (loss)	$	(54.4)	$	1.7	$	(52.7)	$	(42.3)	$	1.5	$	(40.8)

XML

Earnings and Dividends Per Share (Tables)

9 Months Ended

Sep. 30, 2021

Earnings and Dividends Per Share

Summary of earnings (loss) per share calculation

The following is a summary of the earnings (loss) per share calculation for the three and nine months ended September 30, 2021 and 2020 (in millions, except per share data):

	Three months ended				Nine months ended
	September 30,				September 30,
	2021		2020		2021		2020
Net income (loss) attributable to JHG	$	196.8	$	118.9	$	489.6	$	(25.2)
Allocation of earnings to participating stock-based awards		(5.4)		(3.5)		(14.1)		—
Net income (loss) attributable to JHG common shareholders	$	191.4	$	115.4	$	475.5	$	(25.2)
Weighted-average common shares outstanding — basic		167.1		178.4		168.7		180.4
Dilutive effect of nonparticipating stock-based awards		0.7		0.4		0.7		—
Weighted-average common shares outstanding — diluted		167.8		178.8		169.4		180.4
Earnings (loss) per share:
Basic (two class)	$	1.15	$	0.65	$	2.82	$	(0.14)
Diluted (two class)	$	1.14	$	0.65	$	2.81	$	(0.14)

Schedule of anti-dilutive securities that have not been included in the calculation of weighted average diluted shares outstanding

The following instruments are anti-dilutive and have not been included in the weighted-average diluted shares outstanding calculation (in millions):

	Three months ended		Nine months ended
	September 30,		September 30,
	2021	2020	2021	2020
Unvested nonparticipating stock awards	0.3	0.8	0.5	1.5

Schedule of cash dividends declared and paid

The following is a summary of cash dividends paid during the nine months ended September 30, 2021:

Dividend		Date	Dividends paid		Date
per share		declared	(in US$ millions)		paid
$	0.36	February 3, 2021	$	61.7	March 3, 2021
$	0.38	April 28, 2021	$	65.0	May 27, 2021
$	0.38	July 28, 2021	$	64.8	August 25, 2021

XML

Consolidation - VIEs (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Consolidated VIEs
Investment securities	$ 245.3	$ 214.6
Unconsolidated VIEs
Investment securities	$ 99.8	$ 9.6

XML

Consolidation - VREs (Details) - USD ($) $ in Millions	1 Months Ended
	Sep. 30, 2021	Dec. 31, 2020
Consolidated VREs
Investment securities	$ 179.3	$ 29.3
Cash and cash equivalents	2.3	2.8
Other current assets	0.8	0.4
Accounts payable and accrued liabilities	(0.9)	(0.1)
Total	181.5	32.4
Redeemable noncontrolling interests in consolidated VREs	(23.5)
JHG's net interest in consolidated VREs	158.0	32.4
Increase in seed capital investments	163.0
Unconsolidated VREs
Investment securities	$ 56.0	$ 63.6

XML

Investment Securities - General Disclosure (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Short-term investments:
Estimated Fair Value	$ 690.5		$ 690.5		$ 482.7
Unrealized gains on investment securities held at period end	4.6	$ 25.5	8.0	$ 34.1
Seeded investment products
Short-term investments:
Seeded investment products	634.7		634.7		380.7
Investment securities | Separate accounts
Short-term investments:
Seeded investment products	54.2		54.2		63.5
Investment securities | Pooled investment funds
Short-term investments:
Seeded investment products	0.1		0.1		0.1
Investment securities | Investments related to deferred compensation plans
Short-term investments:
Estimated Fair Value	50.3		50.3		96.5
Investment securities | Other investments
Short-term investments:
Estimated Fair Value	5.5		5.5		5.5
Consolidated VIEs | Investment securities
Short-term investments:
Seeded investment products	245.3		245.3		214.6
Consolidated VREs | Investment securities
Short-term investments:
Seeded investment products	179.3		179.3		29.3
Unconsolidated VIEs and VREs | Investment securities
Short-term investments:
Seeded investment products	$ 155.8		$ 155.8		$ 73.2

XML

Investment Securities - Offsetting Derivatives (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Derivative Instrument Denominated in Foreign Currency
Investment gains, net	$ 4.7	$ 25.5	$ 8.1	$ 25.3
Cash flows related to investment securities
Purchases and settlements			(196.5)	48.8
Seeded investment products and derivatives
Derivative Instrument Denominated in Foreign Currency
Investment gains, net	1.4	5.2	4.4	11.2
Third-party ownership interests in seeded investment products
Derivative Instrument Denominated in Foreign Currency
Investment gains, net	3.0	18.1	(1.1)	8.7
Long Tail Alpha equity method investment
Derivative Instrument Denominated in Foreign Currency
Investment gains, net	0.2	0.4	2.1	6.1
Deferred Equity Plan
Derivative Instrument Denominated in Foreign Currency
Investment gains, net	0.2	1.4	2.3	(1.2)
Other investments
Derivative Instrument Denominated in Foreign Currency
Investment gains, net	$ (0.1)	$ 0.4	0.4	0.5
Investment securities
Cash flows related to investment securities
Purchases and settlements			(302.2)	(109.5)
Sales, settlements and maturities			105.7	158.3
Investment securities | Seeded investment products | Consolidated
Cash flows related to investment securities
Purchases and settlements			(66.9)	(69.3)
Sales, settlements and maturities			$ 8.9	$ 4.5

XML

Derivative Instruments (Details) - USD ($) $ in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021	Dec. 31, 2020
Derivatives
Derivative liabilities	$ 1.9	$ 1.9
Net gains (losses) in net income related to:
Securities sold, not yet purchased			$ 7.9
Not Designated as Hedging Instrument
Derivatives
Derivative assets	12.2	12.2	9.1
Derivative liabilities	8.6	8.6	10.8
Futures | Seeded investment products
Derivatives
Notional value of derivative	96.4	96.4	57.0
Futures | Derivative Instruments | Not Designated as Hedging Instrument
Derivatives
Notional value of derivative	373.6	373.6	164.5
Credit default swaps | Seeded investment products
Derivatives
Notional value of derivative	5.5	5.5	1.5
Credit default swaps | Derivative Instruments | Not Designated as Hedging Instrument
Derivatives
Notional value of derivative	164.4	164.4	166.2
Interest rate swaps | Seeded investment products
Derivatives
Notional value of derivative	3.8	3.8	75.0
Total return swaps | Derivative Instruments | Not Designated as Hedging Instrument
Derivatives
Notional value of derivative	59.6	59.6	35.6
Options | Seeded investment products
Derivatives
Notional value of derivative	0.3	0.3	0.5
Forward foreign exchange contracts and swaps | Seeded investment products
Derivatives
Notional value of derivative	83.3	83.3	56.1
Forward foreign exchange contracts and swaps | Derivative Instruments | Not Designated as Hedging Instrument
Derivatives
Notional value of derivative	390.3	390.3	$ 205.0
Forward foreign exchange contracts and swaps | Other non-operating income (expenses), net
Net gains (losses) in net income related to:
Gain on change in fair value of derivatives	$ (0.8)	$ 0.5

XML

Fair Value Measurements - Level of Fair Value (Details) - USD ($) $ in Millions	Sep. 30, 2021	Jun. 30, 2021	Dec. 31, 2020	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Liabilities
Derivative liabilities	$ 1.9
Securities sold, not yet purchased			$ 7.9
Total redeemable noncontrolling interests	145.1		85.8
Seeded investment products
Liabilities
Total redeemable noncontrolling interests	130.2	$ 109.2	70.6	$ 70.8	$ 453.7	$ 662.8
Intech Founders
Liabilities
Total redeemable noncontrolling interests	2.2		2.9
Consolidated | Seeded investment products
Liabilities
Total redeemable noncontrolling interests	130.2		70.6
Consolidated VIEs
Assets
Total investment securities	245.3		214.6
Unconsolidated VIEs
Assets
Total investment securities	99.8		9.6
Fair value measurements, recurring
Assets
Cash equivalents	384.5		525.0
Total assets	1,101.3		1,037.9
Liabilities
Securities sold, not yet purchased	2.9		7.9
Long-term debt	336.8		348.4
Total liabilities	393.6		432.5
Fair value measurements, recurring | Deferred bonuses
Liabilities
Derivative liabilities	42.8
Current portion of long-term debt			65.2
Fair value measurements, recurring | Forward foreign exchange contracts and swaps
Liabilities
Derivative liabilities	1.9
Fair value measurements, recurring | Volantis
Assets
Contingent consideration	2.0		2.8
Fair value measurements, recurring | Geneva
Assets
Contingent consideration	12.0		17.4
Fair value measurements, recurring | Investment securities
Assets
Total investment securities	690.5		482.7
Fair value measurements, recurring | Seed hedge derivatives
Assets
Derivative assets	12.2		9.1
Liabilities
Derivative liabilities	8.6		10.8
Fair value measurements, recurring | Level 1
Assets
Cash equivalents	384.5		525.0
Total assets	997.8		881.6
Liabilities
Securities sold, not yet purchased	2.9		7.9
Total liabilities	2.9		7.9
Fair value measurements, recurring | Level 1 | Investment securities
Assets
Total investment securities	613.3		356.6
Fair value measurements, recurring | Level 2
Assets
Total assets	82.7		124.9
Liabilities
Long-term debt	336.8		348.4
Total liabilities	347.9		359.4
Fair value measurements, recurring | Level 2 | Forward foreign exchange contracts and swaps
Liabilities
Derivative liabilities	1.9
Fair value measurements, recurring | Level 2 | Investment securities
Assets
Total investment securities	70.4		114.9
Fair value measurements, recurring | Level 2 | Seed hedge derivatives
Assets
Derivative assets	12.2		9.1
Liabilities
Derivative liabilities	8.6		10.8
Fair value measurements, recurring | Level 3
Assets
Total assets	20.8		31.4
Liabilities
Total liabilities	42.8		65.2
Fair value measurements, recurring | Level 3 | Deferred bonuses
Liabilities
Derivative liabilities	42.8
Current portion of long-term debt			65.2
Fair value measurements, recurring | Level 3 | Volantis
Assets
Contingent consideration	2.0		2.8
Fair value measurements, recurring | Level 3 | Geneva
Assets
Contingent consideration	12.0		17.4
Fair value measurements, recurring | Level 3 | Investment securities
Assets
Total investment securities	6.8		11.2
Fair value measurements, recurring | Consolidated | Seeded investment products
Assets
Derivative assets	0.1		0.9
Liabilities
Derivative liabilities	0.6		0.2
Fair value measurements, recurring | Consolidated | Level 2 | Seeded investment products
Assets
Derivative assets	0.1		0.9
Liabilities
Derivative liabilities	0.6		0.2
Fair value measurements, recurring | Consolidated VIEs | Investment securities
Assets
Total investment securities	245.3		214.6
Fair value measurements, recurring | Consolidated VIEs | Level 1 | Investment securities
Assets
Total investment securities	194.7		125.7
Fair value measurements, recurring | Consolidated VIEs | Level 2 | Investment securities
Assets
Total investment securities	43.8		77.7
Fair value measurements, recurring | Consolidated VIEs | Level 3 | Investment securities
Assets
Total investment securities	6.8		11.2
Fair value measurements, recurring | Unconsolidated VIEs | Investment securities
Assets
Total investment securities	445.2		268.1
Fair value measurements, recurring | Unconsolidated VIEs | Level 1 | Investment securities
Assets
Total investment securities	418.6		230.9
Fair value measurements, recurring | Unconsolidated VIEs | Level 2 | Investment securities
Assets
Total investment securities	$ 26.6		$ 37.2

XML

Fair Value Measurements - Geneva Contingent Consideration (Details) - USD ($) $ in Millions		3 Months Ended	9 Months Ended
	Mar. 17, 2020	Sep. 30, 2021	Sep. 30, 2021	Sep. 30, 2020	Dec. 03, 2019
Dispositions
Period of time for earnout payments	5 years
Gain on the sale of Geneva				$ 16.2
Receipt of contingent consideration payments from sale of Geneva			$ 5.4	$ 1.6
Geneva
Dispositions
Ownership sold (as a percent)	100.00%				100.00%
Consideration received	$ 38.4
Receipt of contingent consideration payments from sale of Geneva		$ 1.9	$ 5.4
Geneva | Minimum
Dispositions
Contingent consideration	20.5
Geneva | Maximum
Dispositions
Contingent consideration	$ 35.0

XML

Fair Value Measurements - Volantis Contingent Consideration (Details) £ in Millions, $ in Millions			9 Months Ended
	Mar. 17, 2020	Apr. 01, 2017 GBP (£)	Sep. 30, 2021 GBP (£)	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)
Dispositions
Period of performance of investee for recognizing consideration	5 years
Discontinued Operations, Disposed of by Sale
Dispositions
Fair value of contingent consideration				$ 2.0
Business Combination, Contingent Consideration, Asset				$ 2.0
Volantis | Discontinued Operations, Disposed of by Sale
Dispositions
Percentage of share for consideration of sale		10.00%
Period of performance of investee for recognizing consideration		3 years
Fair value of contingent consideration					$ 2.8
Business Combination, Contingent Consideration, Asset					$ 2.8
Certain fund
Dispositions
Percentage of share for consideration of sale		50.00%
Performance fee threshold | £		£ 12	£ 12

XML

Fair Value Measurements - Level 3 Rollforward (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Change in fair value of Level 3 assets
Balance at the beginning of period, Asset value	$ 26.5	$ 29.2	$ 31.4	$ 12.8
Geneva contingent consideration		(1.4)		18.9
Settlements	(5.2)		(9.2)	(2.2)
Purchases of securities		0.2	2.7	0.5
Sales of securities			(1.1)
Fair value adjustments	(0.2)	(1.6)	(2.7)	(3.3)
Foreign currency translation	(0.3)	0.2	(0.3)	(0.1)
Balance at the end of period, Asset value	20.8	26.6	20.8	26.6
Consolidated VIEs
Changes in fair value
Investment securities	245.3		245.3		$ 214.6
Level 3 | Fair value measurements, recurring | Contingent consideration
Changes in fair value
Balance at the beginning of period, Liability Value				21.2
Fair value adjustments				(7.1)
Unrealized gains (losses)				0.3
Distributions				(13.8)
Foreign currency translation				(0.6)
Level 3 | Fair value measurements, recurring | Deferred bonuses
Changes in fair value
Balance at the beginning of period, Liability Value	35.6	42.9	65.2	76.6
Fair value adjustments	1.1	0.8	5.4	(0.3)
Vesting of deferred bonuses	(0.9)	(1.4)	(51.6)	(48.1)
Amortization of deferred bonuses	7.9	8.1	24.0	26.7
Foreign currency translation	(0.9)	1.8	(0.2)	(2.7)
Balance at the end of period, Liability Value	$ 42.8	$ 52.2	$ 42.8	$ 52.2

XML

Goodwill and Intangible Assets (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended		9 Months Ended
	Jun. 30, 2020	Jun. 30, 2021	Mar. 31, 2020	Sep. 30, 2021	Sep. 30, 2020	Mar. 17, 2020	Dec. 03, 2019
Indefinite-lived intangible assets:
Disposal					$ 17.9
Definite-lived intangible assets:
Disposal					17.9
Foreign currency translation					(0.3)
Accumulated amortization, balance at the beginning of the period			$ (147.2)	$ (100.7)	(147.2)
Amortization				(5.8)	(10.5)
Disposal					61.4
Foreign currency translation				1.5	0.6
Accumulated amortization, balance at the end of the period				(105.0)	(95.7)
Net intangible assets
Net intangible assets, balance at the beginning of the period			3,088.6	2,686.3	3,088.6
Amortization				(5.8)	(10.5)
Impairment				(44.4)	(390.2)
Foreign currency translation				(15.2)	(12.5)
Net intangible assets, balance at the end of the period				2,620.9	2,657.5
Goodwill
Goodwill, balance at the beginning of the period			1,504.3	1,383.9	1,504.3
Disposal					(23.5)
Impairment			123.5		123.5
Foreign currency translation				(13.1)	(15.4)
Goodwill, balance at the end of the period				1,370.8	1,341.9
Goodwill and intangible assets impairment				44.4	513.7
Sale
Intangible assets, net				2,620.9	2,657.5
Disposal of goodwill					23.5
Geneva
Goodwill
Disposal						$ (23.5)
Sale
Ownership sold (as a percent)						100.00%	100.00%
Intangible assets, net						$ 17.9
Disposal of goodwill						23.5
Consideration received						$ 38.4
Client relationships
Indefinite-lived intangible assets:
Disposal					79.3
Definite-lived intangible assets:
Balance at the beginning of the period			364.7	170.9	364.7
Disposal					79.3
Impairment			92.6		119.0
Foreign currency translation				(2.9)
Balance at the end of the period				168.0	166.1
VelocityShares ETNs
Goodwill
Goodwill and intangible assets impairment	$ 26.4
Investment management agreements
Indefinite-lived intangible assets:
Balance at the beginning of the period			2,490.3	2,242.9	2,490.3
Impairment			(263.5)	(40.8)
Foreign currency translation				(13.7)	(12.7)
Balance at the end of the period				2,188.4	2,214.1
Indefinite-Lived Intangible Assets				2,188.4	2,214.1
Net intangible assets
Impairment					(263.5)
Certain indefinite-lived Intangible Assets
Indefinite-lived intangible assets:
Impairment		$ (40.8)
Balance at the end of the period		0.0
Indefinite-Lived Intangible Assets		$ 0.0
Trademarks
Indefinite-lived intangible assets:
Balance at the beginning of the period			380.8	373.2	380.8
Impairment			$ (7.7)	(3.6)	(7.7)
Foreign currency translation				(0.1)	(0.1)
Balance at the end of the period				369.5	373.0
Indefinite-Lived Intangible Assets				369.5	$ 373.0
Perkins Trademark
Indefinite-lived intangible assets:
Impairment				$ (3.6)

XML

Goodwill and Intangible Assets - Future Amortization (Details) $ in Millions	Sep. 30, 2021 USD ($)
Future Amortization:
2021 (remainder of year)	$ 1.9
2022	7.6
2023	7.3
2024	5.9
2025	5.9
Thereafter	34.4
Total	$ 63.0

XML

Debt (Details) $ in Millions	9 Months Ended
	Sep. 30, 2021 USD ($)	Dec. 31, 2020 USD ($)
4.875% Senior Notes due 2025
Components of debt
Interest rate (as a percent)	4.875%
Other Disclosures
Face value of debt issued	$ 300.0
4.875% Senior Notes due 2025 | Carrying value
Components of debt
Total debt	311.1	$ 313.3
4.875% Senior Notes due 2025 | Fair value
Components of debt
Total debt	336.8	$ 348.4
Credit Facility
Other Disclosures
Credit facility, maximum borrowing capacity	$ 200.0
Credit facility covenant terms, financing leverage ratio, maximum	3.00
Borrowings under the Credit Facility	$ 0.0
Janus Capital Group Inc | 4.875% Senior Notes due 2025
Other Disclosures
Unamortized premium, net	$ 11.1

XML

Income Taxes (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020	Dec. 31, 2020
Income taxes
Effective tax rate (as a percent)	21.00%	22.90%	26.50%	(15.30%)
Adjustment to deferred tax assets and liabilities			$ 31.0
Unrecognized tax benefits	$ 14.9		14.9		$ 15.8
Anticipated decrease in income tax benefits in the next 12 months	$ 0.6		$ 0.6
UK
Income taxes
Statutory corporation tax rate (as a percentage)	19.00%		19.00%
Enacted tax rate scheduled for April 2023 (as a percent)			25.00%
Statutory corporate tax rate not enacted (as a percent)	17.00%

XML

Noncontrolling Interests - Redeemable (Details) - USD ($) $ in Millions	9 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2020	Jun. 30, 2021	Sep. 30, 2020	Jun. 30, 2020	Dec. 31, 2019
Redeemable Noncontrolling Interests
Total redeemable noncontrolling interests	$ 145.1	$ 85.8
Seeded investment products
Redeemable Noncontrolling Interests
Total redeemable noncontrolling interests	130.2	70.6	$ 109.2	$ 70.8	$ 453.7	$ 662.8
Intech Founders
Redeemable Noncontrolling Interests
Total redeemable noncontrolling interests	$ 2.2	2.9
Remaining interest (as a percent)	1.10%
Consolidated | Seeded investment products
Redeemable Noncontrolling Interests
Total redeemable noncontrolling interests	$ 130.2	70.6
Intech | Intech
Redeemable Noncontrolling Interests
INTECH employee appreciation rights	$ 12.7	$ 12.3

XML

Noncontrolling interests - Seeded Investment Products (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Roll forward of redeemable noncontrolling interests in consolidated seed investment products
Opening balance			$ 85.8
Closing balance	$ 145.1		145.1
Seeded investment products
Roll forward of redeemable noncontrolling interests in consolidated seed investment products
Opening balance	109.2	$ 453.7	70.6	$ 662.8
Changes in market value	3.0	18.8	0.6	10.9
Changes in ownership	18.4	(413.1)	58.5	(610.0)
Foreign currency translation	(0.4)	11.4	0.5	7.1
Closing balance	$ 130.2	$ 70.8	$ 130.2	$ 70.8

XML

Noncontrolling Interests - Nonredeemable (Details) - USD ($) $ in Millions	Sep. 30, 2021	Dec. 31, 2020
Nonredeemable noncontrolling interests
Total nonredeemable noncontrolling interests	$ 15.6	$ 17.4
Seeded investment products
Nonredeemable noncontrolling interests
Total nonredeemable noncontrolling interests	2.9	4.6
Intech
Nonredeemable noncontrolling interests
Total nonredeemable noncontrolling interests	$ 12.7	$ 12.8

XML

Long-Term Incentive and Employee Compensation (Details) - shares shares in Millions	3 Months Ended	9 Months Ended
	Sep. 30, 2021	Sep. 30, 2021
Long-Term Incentive and Employee Compensation
Units granted	1.1	145.0
Minimum
Long-Term Incentive and Employee Compensation
Vesting period		3 years
Maximum
Long-Term Incentive and Employee Compensation
Vesting period		4 years
Restricted Stock Awards
Long-Term Incentive and Employee Compensation
Units granted	1.0	69.5
Mutual Fund Share Awards
Long-Term Incentive and Employee Compensation
Units granted	0.1	75.5

XML

Retirement benefit plans - Actuarial gains(losses), benefit cost, cash flows (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Components of net periodic benefit cost
Service cost	$ (0.2)	$ (0.2)	$ (0.7)	$ (0.6)
Interest cost	(2.8)	(4.3)	(8.4)	(12.9)
Amortization of prior service cost	(0.1)	(0.1)	(0.3)	(0.3)
Expected return on plan assets	3.3	4.7	10.0	13.9
Net periodic benefit credit	$ 0.2	$ 0.1	$ 0.6	$ 0.1

XML

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Changes in accumulated other comprehensive loss, net of tax
Beginning balance			$ 4,716.4
Other comprehensive income (loss), net of tax	$ (59.5)	$ 97.5	(52.7)	$ (40.8)
Less: other comprehensive loss (income) attributable to noncontrolling interests	0.8	(11.0)	(0.2)	(7.3)
Ending balance	4,646.6		4,646.6
Accumulated other comprehensive loss
Changes in accumulated other comprehensive loss, net of tax
Beginning balance	(318.2)	(501.7)	(324.0)	(367.1)
Other comprehensive income (loss)	(59.6)	97.4	(48.8)	(39.5)
Amounts reclassified from accumulated other comprehensive income (loss)	0.1	0.1	(3.9)	(1.3)
Other comprehensive income (loss), net of tax	(59.5)	97.5	(52.7)	(40.8)
Less: other comprehensive loss (income) attributable to noncontrolling interests	0.8	(11.0)	(0.2)	(7.3)
Ending balance	(376.9)	(415.2)	(376.9)	(415.2)
Foreign currency translation adjustments
Changes in accumulated other comprehensive loss, net of tax
Beginning balance	(308.1)	(521.0)	(313.6)	(386.2)
Other comprehensive income (loss)	(59.6)	97.6	(48.9)	(39.5)
Amounts reclassified from accumulated other comprehensive income (loss)		(0.2)	(4.2)	(1.6)
Other comprehensive income (loss), net of tax	(59.6)	97.4	(53.1)	(41.1)
Less: other comprehensive loss (income) attributable to noncontrolling interests	0.8	(11.0)	(0.2)	(7.3)
Ending balance	(366.9)	(434.6)	(366.9)	(434.6)
Retirement benefit asset, net
Changes in accumulated other comprehensive loss, net of tax
Beginning balance	(10.1)	19.3	(10.4)	19.1
Other comprehensive income (loss)		(0.2)	0.1
Amounts reclassified from accumulated other comprehensive income (loss)	0.1	0.3	0.3	0.3
Other comprehensive income (loss), net of tax	0.1	0.1	0.4	0.3
Ending balance	$ (10.0)	$ 19.4	$ (10.0)	$ 19.4

XML

Accumulated Other Comprehensive Loss - OCI (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Accumulated other comprehensive loss
Other comprehensive income, net of tax
Pre-tax amount	$ (60.1)	$ 98.1	$ (54.4)	$ (42.3)
Tax impact	0.6	(0.6)	1.7	1.5
Net amount	(59.5)	97.5	(52.7)	(40.8)
Foreign currency translation adjustments
Other comprehensive income, net of tax
Pre-tax amount	(60.2)	98.2	(50.5)	(41.0)
Tax impact	0.6	(0.6)	1.6	1.5
Net amount	(59.6)	97.6	(48.9)	(39.5)
Retirement benefit asset, net
Other comprehensive income, net of tax
Pre-tax amount		(0.2)
Tax impact			0.1
Net amount		(0.2)	0.1
Reclassification to net income
Other comprehensive income, net of tax
Pre-tax amount	0.1	0.1	(3.9)	(1.3)
Net amount	$ 0.1	$ 0.1	$ (3.9)	$ (1.3)

XML

Earnings and Dividends Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions								3 Months Ended		9 Months Ended
	Oct. 27, 2021	Aug. 25, 2021	Jul. 28, 2021	May 27, 2021	Apr. 28, 2021	Mar. 03, 2021	Feb. 03, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Earnings (loss) per share
Net income (loss) attributable to JHG								$ 196.8	$ 118.9	$ 489.6	$ (25.2)
Allocation of earnings to participating stock-based awards								(5.4)	(3.5)	(14.1)
Net income (loss) attributable to JHG common shareholders								$ 191.4	$ 115.4	$ 475.5	$ (25.2)
Weighted-average common shares outstanding - basic								167.1	178.4	168.7	180.4
Dilutive effect of non-participating stock-based awards								0.7	0.4	0.7
Weighted-average common shares outstanding - diluted								167.8	178.8	169.4	180.4
Earnings per share:
Basic (two class)								$ 1.15	$ 0.65	$ 2.82	$ (0.14)
Diluted (two class)								1.14	0.65	2.81	(0.14)
Dividends Per Share
Dividends paid (per share)								$ 0.38	$ 0.36	$ 1.12	$ 1.08
Cash dividend declared (in dollars per share)	$ 0.38		$ 0.38		$ 0.38		$ 0.36
Cash dividends paid		$ 64.8		$ 65.0		$ 61.7				$ 191.5	$ 198.1
Unvested nonparticipating stock awards
Anti-dilutive securities that have not been included in the calculation of weighted average diluted shares outstanding
Number of anti-dilutive securities that have not been included in the calculation of weighted average diluted shares outstanding								0.3	0.8	0.5	1.5

XML

Commitments and Contingencies (Details) - USD ($) $ in Millions		3 Months Ended		9 Months Ended
	Feb. 09, 2021	Sep. 30, 2021	Sep. 30, 2020	Sep. 30, 2021	Sep. 30, 2020
Related Party Transactions
Shares repurchased amount		$ 75.0	$ 50.2	$ 305.2	$ 103.4
Dai-ichi Life | Secondary Offering
Related Party Transactions
Shares issued	30,668,922
Shares repurchased (shares)	8,048,360
Shares repurchased amount	$ 230.0